Search
Paclitaxel Treatment Options in Canada
A collection of 342 research studies where Paclitaxel is the interventional treatment. These studies are located in the Canada . Paclitaxel is used for conditions such as Breast Cancer, Ovarian Cancer and Non-Small Cell Lung Cancer.
97 - 108 of 342
Show Filters
Match to Clinical Trials
Access to cutting-edge treatments
Latest clinical trials
Find trials in your area
Search by Name
Filter by Condition
Filter by Age
Filter by Type
Gender
Male
Female
Both
Type of Study
Interventional
Observational
Clinical Trial Phase
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
Unknown
Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer
Active Not Recruiting
A study to assess the efficacy and safety of durvalumab in combination with platinum-based chemotherapy (paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial cancer.
A study to assess the efficacy and safety of durvalumab in combination with platinum-based chemotherapy (paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial cancer. Read Less
Gender:
FEMALE
Ages:
Between 18 years and 150 years
Trial Updated:
02/10/2025
Locations: Research Site, Tucson, Arizona +201 locations
Research Site, Tucson, Arizona
Research Site, Concord, California
Research Site, La Jolla, California
Research Site, San Francisco, California
Research Site, Santa Barbara, California
Research Site, Aurora, Colorado
Research Site, Fort Lauderdale, Florida
Research Site, Tampa, Florida
Research Site, Savannah, Georgia
Research Site, Honolulu, Hawaii
Research Site, Arlington Heights, Illinois
Research Site, Chicago, Illinois
Research Site, Indianapolis, Indiana
Research Site, Louisville, Kentucky
Research Site, Baton Rouge, Louisiana
Research Site, Boston, Massachusetts
Research Site, Saint Paul, Minnesota
Research Site, Jackson, Mississippi
Research Site, Lebanon, New Hampshire
Research Site, Camden, New Jersey
Research Site, Paramus, New Jersey
Research Site, New York, New York
Research Site, New York, New York
Research Site, Pinehurst, North Carolina
Research Site, Cleveland, Ohio
Research Site, Cleveland, Ohio
Research Site, Dayton, Ohio
Research Site, Oklahoma City, Oklahoma
Research Site, Tulsa, Oklahoma
Research Site, Eugene, Oregon
Research Site, Tigard, Oregon
Research Site, Pittsburgh, Pennsylvania
Research Site, Providence, Rhode Island
Research Site, Sioux Falls, South Dakota
Research Site, Chattanooga, Tennessee
Research Site, Germantown, Tennessee
Research Site, Knoxville, Tennessee
Research Site, Bedford, Texas
Research Site, Dallas, Texas
Research Site, Houston, Texas
Research Site, San Antonio, Texas
Research Site, Sugar Land, Texas
Research Site, Tyler, Texas
Research Site, Webster, Texas
Research Site, Fairfax, Virginia
Research Site, Norfolk, Virginia
Research Site, Seattle, Washington
Research Site, Morgantown, West Virginia
Research Site, Madison, Wisconsin
Research Site, Milwaukee, Wisconsin
Research Site, Clayton, Not set
Research Site, Malvern, Not set
Research Site, Melbourne, Not set
Research Site, Nedlands, Not set
Research Site, Sydney, Not set
Research Site, Bruges, Not set
Research Site, Bruxelles, Not set
Research Site, Charleroi, Not set
Research Site, Gent, Not set
Research Site, Hasselt, Not set
Research Site, Kortrijk, Not set
Research Site, Leuven, Not set
Research Site, Libramont-Chevigny, Not set
Research Site, Liège, Not set
Research Site, Belo Horizonte, Not set
Research Site, Belo Horizonte, Not set
Research Site, Curitiba, Not set
Research Site, Passo Fundo, Not set
Research Site, Pelotas, Not set
Research Site, Porto Alegre, Not set
Research Site, Porto Alegre, Not set
Research Site, Porto Alegre, Not set
Research Site, Rio de Janeiro, Not set
Research Site, Sao Paulo, Not set
Research Site, Sao Paulo, Not set
Research Site, São José do Rio Preto, Not set
Research Site, Calgary, Alberta
Research Site, Toronto, Ontario
Research Site, Toronto, Ontario
Research Site, Montreal, Quebec
Research Site, Montreal, Quebec
Research Site, Montreal, Quebec
Research Site, Montreal, Quebec
Research Site, Beijing, Not set
Research Site, Beijing, Not set
Research Site, Changchun, Not set
Research Site, Changchun, Not set
Research Site, Changsha, Not set
Research Site, Changsha, Not set
Research Site, Chengdu, Not set
Research Site, Chongqing, Not set
Research Site, Chongqing, Not set
Research Site, Dalian, Not set
Research Site, Dalian, Not set
Research Site, Guangdong, Not set
Research Site, Guangzhou, Not set
Research Site, Haikou, Not set
Research Site, Harbin, Not set
Research Site, Hefei, Not set
Research Site, Nanning, Not set
Research Site, Shanghai, Not set
Research Site, Shenyang, Not set
Research Site, Taiyuan, Not set
Research Site, Tianjin, Not set
Research Site, Wuhan, Not set
Research Site, Wuhan, Not set
Research Site, Zhanjiang, Not set
Research Site, Zhengzhou, Not set
Research Site, Zhengzhou, Not set
Research Site, Barranquilla, Not set
Research Site, Bogota, Not set
Research Site, Bogota, Not set
Research Site, Bogota, Not set
Research Site, Cali, Not set
Research Site, Medellin, Not set
Research Site, Medellín, Not set
Research Site, Monteria, Not set
Research Site, Pereira, Not set
Research Site, Tallinn, Not set
Research Site, Tartu, Not set
Research Site, Bonn, Not set
Research Site, Chemnitz, Not set
Research Site, Dresden, Not set
Research Site, Leipzig, Not set
Research Site, Athens, Not set
Research Site, Chaidari, Not set
Research Site, Thessaloniki, Not set
Research Site, HKG, Not set
Research Site, Hong Kong, Not set
Research Site, Budapest, Not set
Research Site, Budapest, Not set
Research Site, Budapest, Not set
Research Site, Debrecen, Not set
Research Site, Győr, Not set
Research Site, Szolnok, Not set
Research Site, Hisar, Not set
Research Site, Mumbai, Not set
Research Site, Be'er Ya'akov, Not set
Research Site, Hadera, Not set
Research Site, Jerusalem, Not set
Research Site, Nahariya, Not set
Research Site, Tel Aviv, Not set
Research Site, Chuo-ku, Not set
Research Site, Kashiwa-shi, Not set
Research Site, Koto-ku, Not set
Research Site, Kurume-shi, Not set
Research Site, Kyoto-shi, Not set
Research Site, Matsuyama-shi, Not set
Research Site, Minato-ku, Not set
Research Site, Nagoya-shi, Not set
Research Site, Nakagami-gun, Not set
Research Site, Niigata-shi, Not set
Research Site, Osaka-shi, Not set
Research Site, Osaka, Not set
Research Site, Sapporo-shi, Not set
Research Site, Shinjuku-ku, Not set
Research Site, Sunto-gun, Not set
Research Site, Toon-Shi, Not set
Research Site, Tsu-shi, Not set
Research Site, Yokohama-shi, Not set
Research Site, Goyang-si, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Suwon, Not set
Research Site, Yangsan-si, Not set
Research Site, Kaunas, Not set
Research Site, Vilnius, Not set
Research Site, Vilnius, Not set
Research Site, Aguascalientes, Not set
Research Site, Mexico, Not set
Research Site, Monterrey, Not set
Research Site, Oaxaca, Not set
Research Site, Queretaro, Not set
Research Site, San Luis Potosi, Not set
Research Site, Veracruz, Not set
Research Site, Gdansk, Not set
Research Site, Lublin, Not set
Research Site, Olsztyn, Not set
Research Site, Olsztyn, Not set
Research Site, Łódź, Not set
Research Site, Anzorey, Not set
Research Site, Kazan, Tatarstan, Not set
Research Site, Krasnodar, Not set
Research Site, Moscow, Not set
Research Site, Moscow, Not set
Research Site, Saransk, Not set
Research Site, Sochi, Not set
Research Site, St. Petersburg, Not set
Research Site, Singapore, Not set
Research Site, Singapore, Not set
Research Site, Singapore, Not set
Research Site, Barcelona, Not set
Research Site, Barcelona, Not set
Research Site, El Palmar, Not set
Research Site, Girona, Not set
Research Site, Jaén, Not set
Research Site, Madrid, Not set
Research Site, Mallorca, Not set
Conditions: Endometrial Neoplasms
Alpelisib Plus Olaparib in Platinum-resistant/Refractory, High-grade Serous Ovarian Cancer, With no Germline BRCA Mutation Detected
Active Not Recruiting
The objective of this study is to assess the efficacy and safety of the combination of alpelisib and olaparib compared with single agent cytotoxic chemotherapy in patients with platinum resistant or refractory high-grade serous ovarian cancer, with no germline BRCA mutation detected.
The objective of this study is to assess the efficacy and safety of the combination of alpelisib and olaparib compared with single agent cytotoxic chemotherapy in patients with platinum resistant or refractory high-grade serous ovarian cancer, with no germline BRCA mutation detected. Read Less
Gender:
ALL
Ages:
Between 18 years and 100 years
Trial Updated:
02/10/2025
Locations: Arizona Oncology Associates, Phoenix, Arizona +92 locations
Arizona Oncology Associates, Phoenix, Arizona
HonorHealth, Phoenix, Arizona
Florida Cancer Specialists, Fort Myers, Florida
Florida Cancer Specialists, West Palm Beach, Florida
Maryland Oncology Hematology P A, Silver Spring, Maryland
Massachusetts General Hospital, Boston, Massachusetts
Dana Farber Cancer Institute, Boston, Massachusetts
Memorial Sloan Kettering Cancer Ctr, New York, New York
Oncology Hematology Care Inc, Cincinnati, Ohio
University Of Cincinnati, Cincinnati, Ohio
Avera Cancer Institute, Sioux Falls, South Dakota
Sarah Cannon Research Institute, Nashville, Tennessee
Texas Oncology P A, Bedford, Texas
Texas Oncology, Dallas, Texas
Texas Oncology P A, San Antonio, Texas
Texas Oncology Northeast Texas, Tyler, Texas
Novartis Investigative Site, Caba, Buenos Aires
Novartis Investigative Site, Ciudad Autonoma de Bs As, Buenos Aires
Novartis Investigative Site, Buenos Aires, Not set
Novartis Investigative Site, Bedford Park, South Australia
Novartis Investigative Site, Shepparton, Victoria
Novartis Investigative Site, Sydney, Not set
Novartis Investigative Site, Innsbruck, Tyrol
Novartis Investigative Site, Graz, Not set
Novartis Investigative Site, Bruxelles, Not set
Novartis Investigative Site, Leuven, Not set
Novartis Investigative Site, Namur, Not set
Novartis Investigative Site, Belo Horizonte, Minas Gerais
Novartis Investigative Site, Sao Paulo, SP
Novartis Investigative Site, Calgary, Alberta
Novartis Investigative Site, Vancouver, British Columbia
Novartis Investigative Site, London, Ontario
Novartis Investigative Site, Toronto, Ontario
Novartis Investigative Site, Chengdu, Sichuan
Novartis Investigative Site, Beijing, Not set
Novartis Investigative Site, Jinan, Not set
Novartis Investigative Site, Shanghai, Not set
Novartis Investigative Site, Tianjin, Not set
Novartis Investigative Site, Novy Jicin, Czech Republic
Novartis Investigative Site, Ostrava, Poruba
Novartis Investigative Site, Praha, Not set
Novartis Investigative Site, Herlev, Not set
Novartis Investigative Site, Odense C, Not set
Novartis Investigative Site, Kuopio, Not set
Novartis Investigative Site, Tampere, Not set
Novartis Investigative Site, Turku, Not set
Novartis Investigative Site, Besancon Cedex, Not set
Novartis Investigative Site, Lyon, Not set
Novartis Investigative Site, Paris, Not set
Novartis Investigative Site, Pierre Benite, Not set
Novartis Investigative Site, Villejuif, Not set
Novartis Investigative Site, Mannheim, Baden Wuerttemberg
Novartis Investigative Site, Berlin, Not set
Novartis Investigative Site, Dresden, Not set
Novartis Investigative Site, Essen, Not set
Novartis Investigative Site, Bologna, BO
Novartis Investigative Site, Firenze, FI
Novartis Investigative Site, Milano, MI
Novartis Investigative Site, Milano, MI
Novartis Investigative Site, Roma, RM
Novartis Investigative Site, Vicenza, VI
Novartis Investigative Site, Napoli, Not set
Novartis Investigative Site, Seoul, Not set
Novartis Investigative Site, Seoul, Not set
Novartis Investigative Site, Kota Kinabalu, Sabah
Novartis Investigative Site, Kuching, Sarawak
Novartis Investigative Site, Kuala Lumpur, Wilayah Persekutuan
Novartis Investigative Site, Kuala Lumpur, Not set
Novartis Investigative Site, Monterrey, Nuevo Leon
Novartis Investigative Site, Ciudad de Mexico, Not set
Novartis Investigative Site, Eindhoven, Not set
Novartis Investigative Site, Loures, Not set
Novartis Investigative Site, Porto, Not set
Novartis Investigative Site, Arkhangelsk, Not set
Novartis Investigative Site, Singapore, Not set
Novartis Investigative Site, Singapore, Not set
Novartis Investigative Site, Bratislava, Slovak Republic
Novartis Investigative Site, Cordoba, Andalucia
Novartis Investigative Site, Barcelona, Catalunya
Novartis Investigative Site, Barcelona, Catalunya
Novartis Investigative Site, Valencia, Comunidad Valenciana
Novartis Investigative Site, Pamplona, Navarra
Novartis Investigative Site, Madrid, Not set
Novartis Investigative Site, Taichung, Not set
Novartis Investigative Site, Taipei, Not set
Novartis Investigative Site, Taipei, Not set
Novartis Investigative Site, Adana, Not set
Novartis Investigative Site, Ankara, Not set
Novartis Investigative Site, Ankara, Not set
Novartis Investigative Site, Izmir, Not set
Novartis Investigative Site, Glasgow, Not set
Novartis Investigative Site, London, Not set
Novartis Investigative Site, Manchester, Not set
Conditions: Ovarian Cancer
Study of Sacituzumab Govitecan Versus Physician's Choice of Treatment in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread
Active Not Recruiting
The primary objective of this study is to assess overall survival (OS) with sacituzumab govitecan-hziy in comparison with treatment of physician's choice (TPC) in participants with metastatic or locally advanced unresectable urothelial cancer (UC).
The primary objective of this study is to assess overall survival (OS) with sacituzumab govitecan-hziy in comparison with treatment of physician's choice (TPC) in participants with metastatic or locally advanced unresectable urothelial cancer (UC). Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/28/2025
Locations: Mayo Clinic - Arizona, Phoenix, Arizona +233 locations
Mayo Clinic - Arizona, Phoenix, Arizona
UCLA Hematology/ Oncology, Los Angeles, California
University of California Irvine (UCIMC), Orange, California
MedStar Washington Hospital Center, Washington, District of Columbia
Baptist MD Anderson Cancer Center, Jacksonville, Florida
Boca Raton Clinical Research Global USA - Plantation, Plantation, Florida
University of Iowa Hospitals and Clinics, Iowa City, Iowa
University of Maryland School of Medicine, Baltimore, Maryland
Beth Israel Deaconess Medical Center, Boston, Massachusetts
Montefiore Medical Center, Bronx, New York
Roswell Park Cancer Institute, Buffalo, New York
Weill Cornell Medical College, New York, New York
Cleveland Clinic, Cleveland, Ohio
Oklahoma Cancer Specialists and Research Institute (OCSRI), Tulsa, Oklahoma
Penn State Hershey Cancer Institute, Hershey, Pennsylvania
Thompson Oncology Group - Knoxville Downtown, Knoxville, Tennessee
University Cancer Specialists - Knoxville, Knoxville, Tennessee
Harold C. Simmons Comprehensive Cancer Center, Dallas, Texas
Center for Cancer and Blood Disorders, Fort Worth, Texas
Seattle Cancer Care Alliance (SCCA), Seattle, Washington
Summit Cancer Centers, Spokane, Washington
Chris O'Brien Lifehouse, North Ryde, New South Wales
Calvary Mater Newcastle, Waratah, New South Wales
Westmead Hospital, Westmead, New South Wales
Icon Cancer Centre Wesley, Auchenflower, Queensland
Southern Adelaide Local Health Network Incorporated, Bedford Park, South Australia
Ashford Cancer Centre Research - ICON Cancer Centre Adelaide, Kurralta Park, South Australia
ICON Cancer Centre Hobart, Hobart, Tasmania
Monash Health, Clayton, Victoria
Austin Health, Heidelberg, Victoria
Peter MacCallum Cancer Centre, Melbourne, Victoria
Sunshine Hospital, Saint Albans, Victoria
Liverpool Hospital, Nedlands, Western Australia
Sir Charles Gairdner Hospital, Nedlands, Western Australia
Universitätsklinik für Innere Medizin Graz, Graz, Not set
Ordensklinikum Linz GmbH Barmherzige Schwestern, Linz, Not set
Krankenhaus Der Barmherzigen Bruder Wien, Wien, Not set
Grand Hôpital De Charleroi - Notre Dame, Charleroi, Not set
Az Maria Middelares Ghent, Gent, Not set
Universitair Ziekenhuis Gent, Gent, Not set
Universitair Ziekenhuis Leuven, Leuven, Not set
Centre Hospitalier Universitaire de Liège, Liège, Not set
Multiprofile Hospital for Active Treatment Heart and Brain EAD, Pleven, Not set
Specialized Hospital for Active Treatment of Oncological Diseases - Sofia District, Sofia, Not set
Cross Cancer Institute, Edmonton, Not set
qeii health sciences centre - VG site, Halifax, Not set
Juravinski Hospital and Cancer Centre, Hamilton, Not set
London Health Sciences Centre, London, Not set
Jewish General Hospital, Montréal, Not set
McGill University Health Centre, Montréal, Not set
R.S. McLaughlin Durham Regional Cancer Centre, Oshawa, Not set
Princess Margaret Cancer Centre, Toronto, Not set
British Columbia Cancer Agency-Vancouver Centre, Vancouver, Not set
Peking University First Hospital, Beijing, Not set
Chinese People's Liberation Army General Hospital - 301 Hospital, Beijing, Not set
Beijing Cancer Hospital, Beijing, Not set
Chinese Academy of Medical Sciences Cancer Hospital, Beijing, Not set
1st Hospital Jilin University, Changchun, Not set
Hunan Cancer Hospital - Xiangya Hospital - Central South University, Changsha, Not set
West China Hospital Sichuan University, Chengdu, Not set
Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Chengdu, Not set
Chongqing University Cancer Hospital, Chongqing, Not set
The First Affiliated Hospital of Fujian Medical University, Fujian, Not set
Union Hospital of Fujian Medical University, Fuzhou, Not set
Sun Yat-Sen University Cancer Center, Guangzhou, Not set
Zhejiang Provincial People's Hospital - Zhaohui, Hangzhou, Not set
Cancer Hospital of the University of Chinese Academy of Sciences Zhejiang Cancer Hospital, Hangzhou, Not set
Anhui Provincial Cancer Hospital, Hefei, Not set
Qilu Hospital of Shandong University, Jinan, Not set
The First Affiliated Hospital of Nanchang University, Nanchang, Not set
Nanjing Drum Tower Hospital, Nanjing, Not set
Liaoning Cancer Hospital and Institute, Shenyang, Not set
Tianjin Medical University Cancer Institute & Hospital, Tianjin, Not set
Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, Not set
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Not set
Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, Not set
Clinical Hospital Centre Split, Split, Not set
Clinical Hospital Centre "Sestre Milosrdnice", Zagreb, Not set
University Hospital Centre Zagreb, Zagreb, Not set
Fakultni nemocnice Olomouc, Olomouc, Not set
Urocentrum Praha, Praha 2, Not set
Ramsay Health Clinic Belharra, Bayonne, Not set
CHU Saint Andre, Bordeaux, Not set
Centre Hospiltalier Universitaire Brest - Hôpital Morvan, Brest, Not set
Centre Francois Baclesse, Caen Cedex 5, Not set
Centre Jean Perrin, Clermont-Ferrand, Not set
Centre Georges- Francois Leclerc, Dijon, Not set
Centre Hospitalier Departemental Vendee, La Roche-Sur-Yon Cedex, Not set
Centre Oscar Lambret, Lille, Not set
Centre Leon Berard, Lyon, Not set
Institut Régional du Cancer de Montpellier ICM Val d' Aurelle, Montpellier, Not set
Centre Antoine Lacassagne, Nice Cedex 2, Not set
Centre Hospitalier Universitaire de Nimes, Nimes, Not set
Hôpital Européen Georges-Pompidou, Paris, Not set
Centre Eugene Marquis, Rennes Cedex, Not set
Centre Hospitalier Privé Saint-Grégoire, Saint-Grégoire, Not set
Les Hôpitaux Universitaires de Strasbourg, Strasbourg cedex, Not set
Hôpital Foch, Suresnes, Not set
Institut Claudius Regaud, Toulouse Cedex 9, Not set
Institut Gustave Roussy, Villejuif Cedex, Not set
High Technology Hospital MedCenter, Batumi, Not set
New Hospitals, Tbilisi, Not set
L. Managadze National Center of Urology, Tbilisi, Not set
Evex Medical corporation, Tbilisi, Not set
Jerarsi Clinic, Tbilisi, Not set
Universitatsklinik Dresden, Dresden, Not set
Malteser Waldkrankenhaus Erlangen, Erlangen, Not set
Universitätsklinikum Essen, Essen, Not set
Centrum fur Hamatologie und Onkologie Bethanien, Frankfurt/Main, Not set
Asklepios Klinik Altona, Hamburg, Not set
Institut Für Versorgungsforschung in Der Onkologie, Koblenz, Not set
Universitatsklinikum Munster, Münster, Not set
Studienpraxis Urologie, Nürtingen, Not set
Universitätsklinikum Tübingen, Tübingen, Not set
Charité Universitätsmedizin Berlin - Campus Benjamin Franklin, Wien, Not set
401 General Military Hospital of Athens, Athens, Not set
Henry Dunant Hospital, Athens, Not set
Alexandra General Hospital, Athens, Not set
Attikon Hospital, Chaidari, Not set
Regional University General Hospital of Herakleio, Crete, Herakleio, Not set
University Hospital Of Ioannina, Ioannina, Not set
University Hospital of Larissa, Larisa, Not set
Athens Medical Center, Maroussi, Not set
University Hospital of Patras, Patra, Not set
Bioclinic - Thessaloniki, Thessaloniki, Not set
Theagenio Anticancer Hospital of Thessaloniki, Thessaloniki, Not set
Anassa General Clinic, Thessaloniki, Not set
Interbalkan Medical Center of Thessaloniki, Thessaloniki, Not set
Prince of Wales Hospital, Hong Kong, Not set
Queen Mary Hospital, Hong Kong, Not set
Hong Kong United Oncology Centre, Kowloon, Not set
Tallaght University Hospital, Dublin, Not set
University Hospital Waterford, Waterford, Not set
Shamir Medical Center (Assaf Harofeh), Be'er Ya'akov, Not set
Rambam Health Care Campus, Haifa, Not set
Hadassah University Hospital Ein Kerem, Jerusalem, Not set
Meir Medical Center, Kfar-Sava, Not set
Rabin Medical Center, Petach Tikva, Not set
Tel Aviv Medical Center (Ichilov Hospital), Tel Aviv, Not set
Chaim Sheba Medical Center, Tel Hashomer, Not set
Ospedale San Donato, Arezzo, Not set
Centro di Riferimento Oncologico di Aviano, Aviano, Not set
Istituto Tumori Bari Giovanni Paolo II - IRCCS, Bari, Not set
Istituto di Candiolo - Fondazione del Piemonte per l'Oncologia, Candiolo (TO), Not set
Ospedale Policlinico San Martino, Genova, Not set
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Not set
Ospedale San Raffaele, Milan, Not set
Azienda Ospedaliero Universitaria Maggiore Della Carita, Novara, Not set
Azienda Ospedaliero Universitaria Pisana, Pisa, Not set
Istituto Regina Elena, Roma, Not set
Università Campus Bio-Medico di Roma, Rome, Not set
Ospedale Civile Di Sondrio, Sondrio, Not set
Azienda Ospedaliera Santa Maria di Terni, Terni, Not set
Azienda Ospedaliero-Universitaria San Luigi Gonzaga, Torino, Not set
Ospedale di Trento - Presidio Ospedaliero Santa Chiara, Trento, Not set
Azienda Ospedaliera Universitaria Integrata Verona, Verona, Not set
Pusan National University Hospital, Busan-si, Not set
Chungbuk National University Hospital, Cheongju, Not set
Chungnam National University Hospital, Daejeon, Not set
National Cancer Center, Goyang-si, Not set
Pusan National University Yangsan Hospital, Gyeongsangnam-do, Not set
Gachon University Gil Medical Center, Incheon, Not set
Seoul National University Bundang Hospital, Seongnam-si, Not set
Seoul National University Hospital, Seoul, Not set
Severance Hospital, Yonsei University Health System, Seoul, Not set
Asan Medical Center, Seoul, Not set
Samsung Medical Center, Seoul, Not set
The Catholic University of Korea Seoul Saint Mary's Hospital, Seoul, Not set
The Catholic University of Korea Saint Vincent's Hospital, Suwon, Not set
Hospital de Braga, Braga, Not set
Unidade Local de Saúde da Guarda - Hospital Sousa Martins, Guarda, Not set
Centro Hospitalar de Leiria - Hospital de Santo André, Leiria, Not set
Centro Hospitalar de Lisboa Norte - Hospital de Santa Maria, Lisbon, Not set
Instituto Portugues de Oncologia do Porto Francisco Gentil, E.P.E, Porto, Not set
Centro Hospitalar de Tras-os-Montes e Alto Douro, Vila Real, Not set
BRCR Medical Center, Inc, San Juan, Not set
National University Hospital, Singapore, Not set
Icon Cancer Centre Farrer Park, Singapore, Not set
Tan Tock Seng Hospital, Singapore, Not set
Hospital del Mar - Parc de Salut, Barcelona, Not set
Hospital Universitari Vall D'Hebron, Barcelona, Not set
Hospital Clinic de Barcelona, Barcelona, Not set
Hospital Reina Sofia, Córdoba, Not set
Hospital General Universitario Gregorio Maranon, Madrid, Not set
Clínica Universidad de Navarra - Madrid, Madrid, Not set
MD Anderson Cancer Center, Madrid, Not set
Hospital Universitario Ramon y Cajal, Madrid, Not set
Hospital Universitario 12 de Octubre, Madrid, Not set
Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda, Not set
Hospital Sant Joan de Déu de Manresa, Manresa, Not set
Complexo Hospitalario de Ourense (CHOU), Ourense, Not set
Clinica Universidad de Navarra, Pamplona, Not set
Hospital Universitario Marqués de Valdecilla, Santander, Not set
Hospital Universitario Virgen del Rocio, Sevilla, Not set
Álvaro Cunqueiro Hospital, Vigo, Not set
Länssjukhuset Ryhov, Jönköping, Not set
Universitetssjukhuset i Linköping, Linköping, Not set
Karolinska Universitetssjukhuset - Solna, Stockholm, Not set
University Hospital Basel, Basel, Not set
Istituto Oncologico Della Svizzera Italiana (IOSI), Bellinzona, Not set
University of Bern, Bern, Not set
Hôpitaux Universitaires de Genève, Geneva, Not set
Universitaetsspital Zurich - Klinik fur Medizinische Onkologie und Hematologie, Zurich, Not set
Kaohsiung Veterans General Hospital, Kaohsiung, Not set
Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Not set
Taipei Tzu Chi General Hospital, New Taipei City, Not set
Chiayi Chang Gung Memorial Hospital, Puzi, Not set
China Medical University Hospital, Taichung City, Not set
Taichung Veterans General Hospital, Taichung, Not set
National Cheng Kung University Hospital, Tainan, Not set
National Taiwan University Hospital, Taipei City, Not set
Taipei Veterans General Hospital, Taipei City, Not set
Chang Gung Memorial Hospital - Linkou Branch, Taoyuan, Not set
Hacettepe Universitesi Tip Fakultesi- Kanser Enstitusu, Ankara, Not set
Trakya Universitesi Saglik Arastirma ve Uygulama Merkezi, Edirne, Not set
Bagcilar Medipol Mega Universite Hastanesi, Istanbul, Not set
Istanbul Acibadem University Maslak Hospital, Istanbul, Not set
T.C. Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi, Istanbul, Not set
Medical Park Izmır Hastanesi, İzmir, Not set
Cebeci Hastanesi, Mamak, Not set
VKV Amerikan Hastanesi Department of Oncology, Şişli, Not set
University Hospitals Birmingham NHS Foundation Trust, Birmingham, Not set
Dorset County Hospital NHS Foundation Trust, Dorchester, Not set
NHS Greater Glasgow and Clyde, Glasgow, Not set
Barts Health NHS Trust, London, Not set
Guys and Saint Thomas NHS Foundation Trust, Guy's Hospital, London, Not set
Sarah Cannon Research Institute London, London, Not set
The Christie NHS Foundation Trust, Manchester, Not set
East and North Hertfordshire NHS Trust, Middlesex, Not set
Oxford University Hospitals NHS Foundation Trust, Oxford, Not set
Swansea Bay University Health Board, Port Talbot, Not set
Royal Preston Hospital, Preston, Not set
The Royal Marsden NHS Foundation Trust, Surrey, Not set
The Royal Wolverhampton NHS Trust, Wolverhampton, Not set
Conditions: Locally Advanced or Metastatic Unresectable Urothelial Cancer
Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients
Active Not Recruiting
This is a Phase III randomised, double-blind, multi-centre study to evaluate the efficacy and safety of durvalumab in combination with standard of care platinum based chemotherapy and bevacizumab followed by maintenance durvalumab and bevacizumab or durvalumab, bevacizumab and olaparib in patients with newly diagnosed advanced ovarian cancer.
This is a Phase III randomised, double-blind, multi-centre study to evaluate the efficacy and safety of durvalumab in combination with standard of care platinum based chemotherapy and bevacizumab followed by maintenance durvalumab and bevacizumab or durvalumab, bevacizumab and olaparib in patients with newly diagnosed advanced ovarian cancer. Read Less
Gender:
FEMALE
Ages:
Between 18 years and 130 years
Trial Updated:
01/28/2025
Locations: Research Site, Foothill Ranch, California +213 locations
Research Site, Foothill Ranch, California
Research Site, Los Angeles, California
Research Site, Orange, California
Research Site, San Francisco, California
Research Site, Tampa, Florida
Research Site, Augusta, Georgia
Research Site, Hinsdale, Illinois
Research Site, Indianapolis, Indiana
Research Site, Towson, Maryland
Research Site, Detroit, Michigan
Research Site, Springfield, Missouri
Research Site, Middletown, New Jersey
Research Site, Montvale, New Jersey
Research Site, Albany, New York
Research Site, New York, New York
Research Site, Uniondale, New York
Research Site, Durham, North Carolina
Research Site, Cleveland, Ohio
Research Site, Dayton, Ohio
Research Site, Hilliard, Ohio
Research Site, Tulsa, Oklahoma
Research Site, Lancaster, Pennsylvania
Research Site, Philadelphia, Pennsylvania
Research Site, Philadelphia, Pennsylvania
Research Site, Pittsburgh, Pennsylvania
Research Site, Salt Lake City, Utah
Research Site, Graz, Not set
Research Site, Innsbruck, Not set
Research Site, Linz, Not set
Research Site, Wien, Not set
Research Site, Aalst, Not set
Research Site, Leuven, Not set
Research Site, Namur, Not set
Research Site, Oostende, Not set
Research Site, Sint-Niklaas, Not set
Research Site, Barretos, Not set
Research Site, Florianópolis, Not set
Research Site, Fortaleza, Not set
Research Site, Londrina, Not set
Research Site, Porto Alegre, Not set
Research Site, Porto Alegre, Not set
Research Site, Rio de Janeiro, Not set
Research Site, Sao Paulo, Not set
Research Site, São Paulo, Not set
Research Site, Burgas, Not set
Research Site, Plovdiv, Not set
Research Site, Sofia, Not set
Research Site, Varna, Not set
Research Site, Calgary, Alberta
Research Site, Barrie, Ontario
Research Site, Sudbury, Ontario
Research Site, Toronto, Ontario
Research Site, Montreal, Quebec
Research Site, Montreal, Quebec
Research Site, Montreal, Quebec
Research Site, Rimouski, Quebec
Research Site, Quebec, Not set
Research Site, Beijing, Not set
Research Site, Beijing, Not set
Research Site, Bengbu, Not set
Research Site, Changchun, Not set
Research Site, Changsha, Not set
Research Site, Changsha, Not set
Research Site, Chengdu, Not set
Research Site, Chongqing, Not set
Research Site, Dalian, Not set
Research Site, Guangzhou, Not set
Research Site, Guangzhou, Not set
Research Site, Hangzhou, Not set
Research Site, Hangzhou, Not set
Research Site, Harbin, Not set
Research Site, Hefei, Not set
Research Site, Jinhua, Not set
Research Site, Kunming, Not set
Research Site, Lanzhou, Not set
Research Site, Luzhou, Not set
Research Site, Nan Chong, Not set
Research Site, Nanjing, Not set
Research Site, Nanning, Not set
Research Site, Nantong, Not set
Research Site, Shanghai, Not set
Research Site, Shanghai, Not set
Research Site, Wuhan, Not set
Research Site, Wuhan, Not set
Research Site, Xi'an, Not set
Research Site, Zhengzhou, Not set
Research Site, Zhengzhou, Not set
Research Site, Zhuhai, Not set
Research Site, Aalborg, Not set
Research Site, Aarhus N, Not set
Research Site, Odense, Not set
Research Site, Roskilde, Not set
Research Site, Vejle, Not set
Research Site, Kuopio, Not set
Research Site, Oulu, Not set
Research Site, Turku, Not set
Research Site, Besançon, Not set
Research Site, Bordeaux, Not set
Research Site, Limoges Cedex, Not set
Research Site, Lyon Cedex 08, Not set
Research Site, Marseille, Not set
Research Site, Nantes, Not set
Research Site, Paris Cedex 14, Not set
Research Site, Paris, Not set
Research Site, Paris, Not set
Research Site, Saint Herblain Cedex, Not set
Research Site, Vandoeuvre les Nancy, Not set
Research Site, Bad Homburg, Not set
Research Site, Berlin, Not set
Research Site, Bielefeld, Not set
Research Site, Bonn, Not set
Research Site, Brandenburg, Not set
Research Site, Dresden, Not set
Research Site, Düsseldorf, Not set
Research Site, Essen, Not set
Research Site, Essen, Not set
Research Site, Esslingen am Neckar, Not set
Research Site, Frankfurt, Not set
Research Site, Freiburg, Not set
Research Site, Fürth, Not set
Research Site, Greifswald, Not set
Research Site, Gütersloh, Not set
Research Site, Hamburg, Not set
Research Site, Hamburg, Not set
Research Site, Hamburg, Not set
Research Site, Hannover, Not set
Research Site, Hannover, Not set
Research Site, Jena, Not set
Research Site, Karlsruhe, Not set
Research Site, Karlsruhe, Not set
Research Site, Kassel, Not set
Research Site, Kiel, Not set
Research Site, Köln, Not set
Research Site, Leipzig, Not set
Research Site, Ludwigsburg, Not set
Research Site, Lübeck, Not set
Research Site, Mainz, Not set
Research Site, Mannheim, Not set
Research Site, München, Not set
Research Site, Offenbach am Main, Not set
Research Site, Oldenburg, Not set
Research Site, Rosenheim, Not set
Research Site, Rostock, Not set
Research Site, Saalfeld, Not set
Research Site, Schweinfurt, Not set
Research Site, Tübingen, Not set
Research Site, Ulm, Not set
Research Site, Worms, Not set
Research Site, Budapest, Not set
Research Site, Budapest, Not set
Research Site, Debrecen, Not set
Research Site, Győr, Not set
Research Site, Kaposvár, Not set
Research Site, Szeged, Not set
Research Site, Zalaegerszeg, Not set
Research Site, Brescia, Not set
Research Site, Lecce, Not set
Research Site, Lecco, Not set
Research Site, Milano, Not set
Research Site, Milano, Not set
Research Site, Mirano, Not set
Research Site, Napoli, Not set
Research Site, Reggio Calabria, Not set
Research Site, Reggio Emilia, Not set
Research Site, Roma, Not set
Research Site, Torino, Not set
Research Site, Torino, Not set
Research Site, Fukuoka-shi, Not set
Research Site, Kashiwa-shi, Not set
Research Site, Kobe-shi, Not set
Research Site, Koto-ku, Not set
Research Site, Kurume-shi, Not set
Research Site, Kyoto-shi, Not set
Research Site, Minato-ku, Not set
Research Site, Nagoya-shi, Not set
Research Site, Niigata-shi, Not set
Research Site, Okayama-shi, Not set
Research Site, Sapporo-shi, Not set
Research Site, Sendai-shi, Not set
Research Site, Shinjuku-ku, Not set
Research Site, Sunto-gun, Not set
Research Site, Toyoake-shi, Not set
Research Site, Goyang-si, Not set
Research Site, Seongnam-si, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Suwon-si, Not set
Research Site, Bellavista, Not set
Research Site, La Libertad, Not set
Research Site, Lima, Not set
Research Site, Lima, Not set
Research Site, Lima, Not set
Research Site, Lima, Not set
Research Site, San Isidro, Not set
Research Site, Gdynia, Not set
Research Site, Szczecin, Not set
Research Site, Warszawa, Not set
Research Site, Warszawa, Not set
Research Site, Łódź, Not set
Research Site, Floresti, Not set
Research Site, Córdoba, Not set
Research Site, Madrid, Not set
Research Site, Madrid, Not set
Research Site, Madrid, Not set
Research Site, Madrid, Not set
Research Site, Terrassa(Barcelona), Not set
Research Site, Vigo, Not set
Research Site, Adana, Not set
Research Site, Ankara, Not set
Research Site, Ankara, Not set
Research Site, Istanbul, Not set
Research Site, Istanbul, Not set
Research Site, Izmir, Not set
Conditions: Advanced Ovarian Cancer
CHemotherapy and Stool Transplant in PDAC (CHASe-PDAC)
Recruiting
To confirm the safety of combining oral fecal microbiota transplantation (FMT) with gemcitabine and nab-paclitaxel chemotherapy as first line treatment in patients with unresectable or metastatic pancreatic ductal adenocarcinoma.
To confirm the safety of combining oral fecal microbiota transplantation (FMT) with gemcitabine and nab-paclitaxel chemotherapy as first line treatment in patients with unresectable or metastatic pancreatic ductal adenocarcinoma. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/21/2025
Locations: Verspeeten Family Cancer Centre (formerly known as the London Regional Cancer Program) London Health Sciences Centre, London, Ontario
Verspeeten Family Cancer Centre (formerly known as the London Regional Cancer Program) London Health Sciences Centre, London, Ontario
Conditions: Unresectable or Metastatic Advanced Pancreatic Ductal Adenocarcinoma
Avelumab in First-line NSCLC (JAVELIN Lung 100)
Completed
The purpose of this study was to demonstrate superiority with regard to Overall Survival (OS) or Progression Free Survival (PFS) of avelumab versus platinum-based doublet, based on an Independent Review Committee assessment, in Non-small cell lung cancer (NSCLC) participants with Programmed death ligand 1+ (PD-L1+) tumors.
The purpose of this study was to demonstrate superiority with regard to Overall Survival (OS) or Progression Free Survival (PFS) of avelumab versus platinum-based doublet, based on an Independent Review Committee assessment, in Non-small cell lung cancer (NSCLC) participants with Programmed death ligand 1+ (PD-L1+) tumors. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/20/2025
Locations: Clearview Cancer Institute, Huntsville, Alabama +348 locations
Clearview Cancer Institute, Huntsville, Alabama
Arizona Center for Cancer Care, Surprise, Arizona
Sharp Memorial Hospital, San Diego, California
University Cancer Institute, Boynton Beach, Florida
South Georgia Medical Center, Valdosta, Georgia
Christus Cancer Treatment Center, Shreveport, Louisiana
Henry Ford Hospital, Detroit, Michigan
St. Vincent Frontier Cancer Center, Billings, Montana
Nevada Cancer Research Foundation, Las Vegas, Nevada
San Juan Oncology Associates, Farmington, New Mexico
Novant Health Oncology Specialists, Kernersville, North Carolina
Mercy Research, Oklahoma City, Oklahoma
Kaiser Permanente Northwest, Portland, Oregon
Lancaster Cancer Center, Lancaster, Pennsylvania
Cookeville Regional Medical Center, Cookeville, Tennessee
Thompson Cancer Survival Center, Knoxville, Tennessee
Coastal Bend Cancer Center, Corpus Christi, Texas
Oncology Consultants, P.A., Houston, Texas
University of Vermont Medical Center, Burlington, Vermont
Northwest Medical Specialties, PLLC, Tacoma, Washington
Cheyenne Regional Medical Center, Cheyenne, Wyoming
Albury Wodonga Regional Cancer Centre, Albury, New South Wales
Coffs Harbour Health Campus, Coffs Harbour, New South Wales
St George Private Hospital, Kogarah, New South Wales
Lismore Base Hospital, Lismore, New South Wales
Orange Health Service, Orange, New South Wales
Royal North Shore Hospital, St Leonards, New South Wales
Calvary Mater Newcastle, Waratah, New South Wales
Gallipoli Medical Research Foundation Ltd, Greenslopes, Queensland
Gold Coast University Hospital, Southport, Queensland
The Queen Elizabeth Hospital, Woodville South, South Australia
Ballarat Base Hospital, Ballarat, Victoria
Bendigo Hospital, Bendigo, Victoria
South West Healthcare, Warrnambool, Victoria
Fiona Stanley Hospital, Murdoch, Western Australia
ZNA Middelheim, Antwerpen, Not set
A.Z. Klina, Brasschaat, Not set
CHU Ambroise Paré, Mons, Not set
NOB - Núcleo de Oncologia da Bahia, Salvador, Bahia
CRIO - Centro Regional Integrado de Oncologia, Fortaleza, Ceará
CEBROM - Centro Brasileiro de Radioterapia, Oncologia e Mastologia, Goiânia, Goiás
Hospital Erasto Gaertner - Liga Paranaense de Combate ao Câncer, Curitiba, Paraná
Hospital de Caridade de Ijuí, Ijuí, Rio Grande Do Sul
Hospital Bruno Born, Lajeado, Rio Grande Do Sul
Hospital São Vicente de Paulo, Passo Fundo, Rio Grande Do Sul
Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul
IMV-Pesquisa Cardiologica Sociedade Simples - HMD - COR, Porto Alegre, Rio Grande Do Sul
Hospital São Lucas da PUCRS, Porto Alegre, Rio Grande Do Sul
Hospital Nossa Senhora da Conceição, Porto Alegre, Rio Grande Do Sul
CEPON - Centro de Pesquisas Oncológicas de Santa Catarina, Florianópolis, Santa Catarina
Clínica de Neoplasias Litoral Ltda., Itajaí, Santa Catarina
Hospital de Câncer de Barretos - Fundação Pio XII, Barretos, Sao Paulo
Fundação Doutor Amaral Carvalho, Jaú, Sao Paulo
CEPHO - Centro de Estudos e Pesquisas em Hematologia e Oncologia, Santo Andre, Sao Paulo
Fundação Faculdade Regional de Medicina de São José do Rio Preto, São José do Rio Preto, Sao Paulo
ICESP - Instituto do Câncer do Estado de São Paulo Octavio Frias de Oliveira, São Paulo, Sao Paulo
IBCC - Instituto Brasileiro de Controle do Câncer, São Paulo, Sao Paulo
INCA - Instituto Nacional de Câncer, Rio de Janeiro, Not set
Complex Oncological Center - Ruse, EODD, Ruse, Not set
MHAT for women's health - Nadezhda, OOD, Sofia, Not set
UMHAT "Sv. Ivan Rilski", EAD, Sofia, Not set
Shato, Ead, Sofia, Not set
The Moncton Hospital, Moncton, New Brunswick
Mount Sinai Hospital, Toronto, Ontario
FALP - Fundación Arturo López Pérez, Santiago, Not set
Clinica Santa Maria, Santiago, Not set
IRAM - Instituto de Radio Medicina, Santiago, Not set
Hospital Militar de Santiago, Santiago, Not set
Hospital Clínico San Borja Arriaran, Santiago, Not set
Hospital Clínico Universidad de Chile, Santiago, Not set
Hospital Clinico Viña del Mar, Viña del Mar, Not set
Centro de Investigaciones Clinicas Viña del Mar, Viña del Mar, Not set
Beijing Cancer Hospital, Beijing, Beijing
Guangdong General Hospital, Guangzhou, Guangdong
Harbin Medical University Cancer Hospital, Harbin, Heilongjiang
Liaoning Cancer Hospital & Institute, Shenyang, Liaoning
Linyi Cancer Hospital, Linyi, Shandong
Administradora Country S.A., Bogotá, Not set
Fundación Oftalmológica de Santander - FOSCAL, Floridablanca, Not set
Hospital Pablo Tobón Uribe, Medellín, Not set
IPS IMAT- Instituto Medico de Alta Tecnologia - Oncomedica S.A., Monteria, Not set
University Clinic for Pulmonary Diseases, Zagreb, Not set
University Hospital Centre "Sestre Milosrdnice", Zagreb, Not set
Bank of Cyprus Oncology Center, Nicosia, Not set
Krajska nemocnice Liberec, a.s., Liberec, Not set
Nemocnice Na Plesi s.r.o., Nova Ves pod Plesi, Not set
Fakultni nemocnice Olomouc, Olomouc, Not set
Vitkovicka nemocnice a.s, Ostrava - Vitkovice, Not set
Thomayerova nemocnice, Praha 4 - Krc, Not set
Krajska zdravotni, a.s. - Masarykova nemocnice v Usti nad Labem, o.z., Usti nad Labem, Not set
Herning Sygehus, Herning, Not set
Roskilde Sygehus, Roskilde, Not set
North Estonia Medical Centre Foundation, Tallinn, Not set
Centre Antoine Lacassagne, Nice cedex 02, Alpes Maritimes
CHU de Strasbourg - Nouvel Hôpital Civil, Strasbourg, Bas Rhin
Hôpital Nord - AP-HM Marseille#, Marseille cedex 20, Bouches-du-Rhône
Hôpital privé Clairval, Marseille, Bouches-du-Rhône
CHU Besançon - Hôpital Jean Minjoz, Besancon Cedex, Doubs
CHU Brest - Hôpital Morvan, Brest Cedex, Finistere
Groupe Hospitalier Sud - Hôpital Haut-Lévêque, Pessac, Gironde
CHU Angers - Hôpital Hôtel Dieu#, Angers Cedex 9, Maine Et Loire
Hôpital Cochin, Paris cedex 14, Paris
Centre Hospitalier de la Côte Basque, Bayonne, Pyrenees Atlantiques
Centre Hospitalier de la Croix Rousse, Lyon cedex 04, Rhone
Clinique Victor Hugo - Centre Jean Bernard, Le Mans Cedex 02, Sarthe
Institut Sainte Catherine, Avignon Cedex 9, Vaculuse
Centre Hospitalier Intercommunal de Créteil, Creteil cedex, Val De Marne
Hôpital Saint-Louis - Paris, Paris Cedex 10, Not set
Universitaetsklinikum Heidelberg, Heidelberg, Baden Wuerttemberg
LungenClinic Grosshansdorf GmbH, Grosshansdorf, Schleswig Holstein
251 General Air Force Hospital, Athens, Not set
General Hospital of Athens of Chest Diseases "SOTIRIA", Athens, Not set
University General Hospital "Attikon", Athens, Not set
General Oncology Hospital of Kifissia " Agioi Anargyroi", Athens, Not set
Metropolitan General Hospital, Athens, Not set
University General Hospital of Heraklion, Heraklion, Not set
University General Hospital of Patra, Patras, Not set
Euromedica General Clinic Thessaloniki, Thessaloniki, Not set
Orszagos Koranyi Pulmonologiai Intezet, Budapest, Not set
Orszagos Onkologiai Intezet, Budapest, Not set
Semmelweis Egyetem, Budapest, Not set
Orszagos Koranyi Pulmonologiai Intezet, Budapest, Not set
Csongrad Megyei Mellkasi Betegsegek Szakkorhaza, Deszk, Not set
Petz Aladar Megyei Oktato Korhaz, Györ, Not set
Borsod-Abauj-Zemplen Megyei Kozponti Korhaz es Egyetemi Oktatokorhaz, Miskolc, Not set
SzSzB Megyei Korhazak es Egyetemi Oktatokorhaz, Nyiregyhaza, Not set
Tolna Megyei Balassa Janos Korhaz, Szekszard, Not set
Tudogyogyintezet Torokbalint, Torokbalint, Not set
Zala Megyei Szent Rafael Korhaz, Zalaegerszeg, Not set
Cork University Hospital, Cork, Not set
Soroka University Medical Center, Beer Sheva, Not set
Rambam Health Care Center, Haifa, Not set
Hadassah University Hospital - Ein Kerem, Jerusalem, Not set
Sapir Medical Center, Meir Hospital, Kfar-Saba, Not set
Rabin Medical Center-Beilinson Campus, Petach Tikva, Not set
Chaim Sheba Medical Center, Ramat Gan, Not set
Kaplan Medical Center, Rechovot, Not set
Assaf Harofeh, Rishon Lezion, Not set
Tel Aviv Sourasky Medical Center, Tel Aviv, Not set
Ospedale Mater Salutis, Legnago, Verona
Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Not set
Presidio Ospedaliero Garibaldi Nesima, Catania, Not set
Azienda Ospedaliero Universitaria San Martino, Genova, Not set
Seconda Università degli Studi di Napoli, Napoli, Not set
Azienda Ospedaliero Universitaria di Parma, Parma, Not set
Azienda Ospedaliero Universitaria Pisana, Pisa, Not set
National Cancer Center Hospital East, Kashiwa-shi, Chiba-Ken
Kurume University Hospital, Kurume-shi, Fukuoka-Ken
NHO Hokkaido Cancer Center, Sapporo-shi, Hokkaido
Institute of Biomedical Research and Innovation Hospital, Kobe-shi, Hyogo-Ken
Kobe City Hospital Organization Kobe City Medical Center General Hospital, Kobe-shi, Hyogo-Ken
Yokohama Municipal Citizen's Hospital, Yokohama-shi, Kanagawa-Ken
Kanagawa Cancer Center, Yokohama-shi, Kanagawa-Ken
Kansai Medical University Hospital, Hirakata-shi, Osaka-Fu
Osaka Medical College Hospital, Takatsuki-shi, Osaka-Fu
National Cancer Center Hospital, Chuo-ku, Tokyo-To
Tokyo Medical University Hospital, Shinjuku-ku, Tokyo-To
Toyama University Hospital, Toyama-shi, Toyama-Ken
Kobe City Hospital Organization Kobe City Medical Center General Hospital, Kobe-shi, Not set
Chungbuk National University Hospital, Cheongju-si, Chungcheongbuk-do
Yonsei University Wonju Severance Christian Hospital, Wonju-si, Gangwon-do
Inje University Haeundae Paik Hospital, Busan, Gyeonggi-do
National Cancer Center, Goyang-si, Gyeonggi-do
CHA Bundang Medical Center, CHA University, Seongnam-si, Gyeonggi-do
Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do
The Catholic University of Korea, St. Vincent's Hospital, Suwon-si, Gyeonggi-do
Ajou University Hospital, Suwon-si, Gyeonggi-do
Kyungpook National University Chilgok Hospital, Daegu, Not set
Gachon University Gil Medical Center, Incheon, Not set
Korea University Anam Hospital, Seoul, Not set
Seoul National University Hospital, Seoul, Not set
Severance Hospital, Yonsei University, Seoul, Not set
Asan Medical Center, Seoul, Not set
Samsung Medical Center, Seoul, Not set
The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Not set
The Catholic University of Korea, Yeouido St. Mary's Hospital, Seoul, Not set
Korea University Guro Hospital, Seoul, Not set
Ulsan University Hospital, Ulsan, Not set
American University of Beirut Medical Center, Beirut, Not set
Rafik Hariri University Hospital, Beirut, Not set
Hotel Dieu de France Hospital, Beirut, Not set
Mount Lebanon Hospital, Beirut, Not set
Hammoud Hospital University Medical Center, Saida, Not set
Hospital of Lithuanian University of Health Sciences Kaunas Clinics, Kaunas, Not set
Martini Ziekenhuis, Groningen, Not set
Westfriesgasthuis - PARENT, Hoorn, Not set
ETZ Elisabeth, Tilburg, Not set
Auckland City Hospital, Auckland, Not set
Dunedin Public Hospital, Dunedin, Not set
Waikato Hospital, Hamilton, Not set
Palmerston North Hospital, Palmerston North, Not set
Tauranga Hospital, Tauranga, Not set
Wellington Hospital, Wellington, Not set
Instituto Nacional de Enfermedades Neoplásicas, Lima, Not set
Clinica Internacional Sede San Borja, Lima, Not set
Oncosalud, Lima, Not set
Centrum Terapii Wspolczesnej J.M. Jasnorzewska sp. komandytowo-akcyjna, Lodz, Not set
Instytut MSF Sp. o.o, Lodz, Not set
Wojewódzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Łodzi, Lodz, Not set
KO-MED Centra Kliniczne Lublin II, Lublin, Not set
SSZZOZ im. Dr Teodora Dunina w Rudce, Mrozy, Not set
SP Zespol Gruzlicy i Chorob Pluc w Olsztynie, Olsztyn, Not set
Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy, Otwock, Not set
Szpital Kliniczny Przemienienia Panskiego Uniwersytetu Medycznego im. Karola Marcinkowskiego, Poznan, Not set
Izerskie Centrum Pulmonologii i Chemioterapii "IZER-MED" Spolka z o.o., Szklarska Poręba, Not set
Centrum Onkologii-Instytut im. M. Sklodowskiej Curie, Warszawa, Not set
Mazowiecki Szpital Onkologiczny, Wieliszew, Not set
Hospital Garcia de Orta, EPE, Almada, Not set
Hospital Professor Doutor Fernando Fonseca, E.P.E., Amadora-Lisbon, Not set
Centro Hospitalar De Coimbra-CHUC, Coimbra, Not set
Centro Hospitalar e Universitário de Coimbra, E.P.E (CHC), Coimbra, Not set
Centro Hospitalar de Lisboa Norte, E.P.E. - Hospital Pulido Valente, Lisboa, Not set
Centro Hospitalar de Lisboa Central, E.P.E. - Hospital de Santo António dos Capuchos, Lisboa, Not set
Centro Hospitalar do Porto, E.P.E. - Hospital de Santo António, Porto, Not set
Hospital CUF Porto, Porto, Not set
Instituto Português de Oncologia do Porto Francisco Gentil, EPE, Porto, Not set
Centro Hospitalar de São João, E.P.E., Porto, Not set
Centro Hospitalar de Entre o Douro e Vouga, E.P.E - Hospital de São Sebastião, Santa Maria da Feira, Not set
Centro Hospitalar Vila Nova de Gaia/Espinho, E.P.E, Vila Nova de Gaia, Not set
Spitalul Judetean de Urgenta "Dr. Constantin Opris" Baia Mare, Baia Mare, Not set
S.C Policlinica de Diagnostic Rapid S.A, Brasov, Not set
Institutul Oncologic "Prof. Dr. Al. Trestioreanu", Bucuresti, Not set
Spitalul Clinic Coltea, Bucuresti, Not set
S.C Gral Medical S.R.L, Bucuresti, Not set
Institutul Oncologic "Prof. Dr. Ion Chiricuta" Cluj Napoca, Cluj Napoca, Not set
S.C Medisprof S.R.L, Cluj-Napoca, Not set
Spitalul Militar de Urgenta "Dr.Constantin Papilian"Cluj -Napoca, Cluj-Napoca, Not set
S.C Radiotherapy Center Cluj S.R.L, Comuna Floresti, Not set
Spitalul Clinic Judetean de Urgenta "Sf. Apostol Andrei" Constanta, Constanta, Not set
S.C Centrul de Oncologie Sf. Nectarie S.R.L, Craiova, Not set
Institutul Regional de Oncologie Iasi, Iasi, Not set
S.C Pelican Impex S.R.L, Oradea, Not set
Spitalul Clinic Municipal "Dr. Gavril Curteanu" Oradea, Oradea, Not set
Spitalul Judetean de Urgenta "Sf. Ioan cel Nou" Suceava, Suceava, Not set
S.C Oncocenter Oncologie Clinica S.R.L, Timisoara, Not set
S.C Oncomed S.R.L, Timisoara, Not set
SBIH of Arkhangelsk region "Arkhangelsk Clinical Oncological Dispensary", Arkhangelsk, Not set
LLC Evimed, Chelyabinsk, Not set
Chelyabinsk Regional Oncology Dispensary, Chelyabinsk, Not set
Irkutsk Regional Oncology Dispensary, Irkutsk, Not set
RBIH "Ivanovo Regional Oncological Dispensary", Ivanovo, Not set
SBHI of Kaluga Region "Kaluga regional clinical oncology dispensary", Kaluga, Not set
SAIH "Republican Clinical Oncological Dispensary of the Ministry of Healthcare of Republic Tatarstan, Kazan, Not set
Kemerovo SPI Regional Clinical Oncology Dispensary, Kemerovo, Not set
SBHI "Krasnoyarsk Regional Oncology Dispensary n.a. A.I. Kryzhanovsky", Krasnoyarsk, Not set
RBIH "Kursk regional clinical oncology dispensary" of Kursk Region Healthcare Committee, Kursk, Not set
FSBSI "Russian Oncological Scientific Center n.a. N.N. Blokhin", Moscow, Not set
Murmansk Regional Clinical Hospital named after Bayandin, Murmansk, Not set
SBHI of Novosibirsk region "Novosibirsk Regional Oncological Dispensary", Novosibirsk, Not set
SBIH of Stavropol territory "Pyatigorsk Oncological Dispensary", Pyatigorsk, Not set
SBIH "Leningrad Regional Oncological Dispensary", Saint-Petersburg, Not set
"Bio Eq" LLC, Saint-Petersburg, Not set
FBI "Scientific Research Institute of Oncology n. a. N. N. Petrov", Saint-Petersburg, Not set
SBIH "Samara Regional Clinical Oncological Dispensary", Samara, Not set
SBIH "Oncological Dispensary # 2" of the MoH of Krasnodar territory, Sochi, Not set
FSBHI Clinical research institute of phthisiopulmonology, St. Petersburg, Not set
Tomsk Research Instutite of Oncology, Tomsk, Not set
BHI of Omsk region "Clinical Oncology Dispensary", Tomsk, Not set
Medicinskiy gorod, Tyumen, Not set
SBIH of Yaroslavl region "Regional Clinical Oncological Hospital", Yaroslavl, Not set
Clinical Center of Serbia, Belgrade, Not set
Institute of Oncology and Radiology of Serbia, Belgrade, Not set
Military Medical Academy, Belgrade, Not set
Clinical Center Bezanijska Kosa, Belgrade, Not set
Clinical Center Nis, Pulmonary Diseases Clinic, Gornji Matejevac, Not set
Clinical Center Kragujevac, Kragujevac, Not set
Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Not set
National University Cancer Institute, Singapore, Not set
National Cancer Centre, Singapore, Not set
Tan Tock Seng Hospital, Singapore, Not set
Nemocnica s poliklinikou Sv. Jakuba, n.o. Bardejov, Bardejov, Not set
Univerzitna nemocnica Bratislava, Nemocnica Ruzinov, Bratislava, Not set
Emery Clinical Services, Alberton, Gauteng
University of Pretoria Oncology Department, Pretoria, Gauteng
Johese Clinical Research, Pretoria, Gauteng
Cape Town Oncology Trials Pty Ltd, Cape Town, Western Cape
Hospital de Mataro, Mataro, Barcelona
Hospital Universitario Mutua de Terrassa, Terrassa, Barcelona
Hospital Universitario Donostia, San Sebastian, Guipuzcoa
Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, La Coruña
Complejo Hospitalario Universitario de Vigo, Vigo, Pontevedra
Specialist, Barcelona, Not set
Hospital Universitari Quiron Dexeus, Barcelona, Not set
Hospital Universitari Vall d'Hebron, Barcelona, Not set
Hospital de la Santa Creu i Sant Pau, Barcelona, Not set
ICO Girona - Hospital Universitari de Girona Dr. Josep Trueta, Girona, Not set
Hospital General Universitario Gregorio Marañon, Madrid, Not set
MD Anderson Cancer Centre, Madrid, Not set
Fundacion Jimenez Diaz, Madrid, Not set
Hospital Universitario La Paz, Madrid, Not set
Hospital Regional Universitario de Malaga, Málaga, Not set
Hospital Quiron Sagrado Corazon, Sevilla, Not set
Hospital Universitario Virgen del Rocio, Sevilla, Not set
Hospital Txagorritxu, Vitoria, Not set
Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Not set
China Medical University Hospital, Taichung, Not set
Taichung Veterans General Hospital, Taichung, Not set
National Taiwan University Hospital, Taipei, Not set
Taipei Veterans General Hospital, Taipei, Not set
Tri-Service General Hospital, Taipei, Not set
Chang Gung Memorial Hospital, Linkou, Taoyuan County, Not set
King Chulalongkorn Memorial Hospital, Patumwan, Bangkok
Rajavithi Hospital, Rajathevee, Bangkok
Maharaj Nakorn Chiang Mai Hospital, Muang, Chiang Mai
Srinagarind Hospital, Muang, Khon Kaen
Naresuan University Hospital, Muang, Phitsanulok
Songklanagarind Hospital, Hat Yai, Songkhla
Siriraj Hospital, Bangkok, Not set
Acibadem Adana Hospital, Adana, Not set
Baskent University Adana Application and Research Center, Adana, Not set
Adana Numune Training and Research Hospital, Adana, Not set
Cukurova University Medical Faculty, Adana, Not set
Adana City Hospital, Adana, Not set
Ankara University Medical Faculty, Ankara, Not set
Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Not set
Hacettepe University Medical Faculty, Ankara, Not set
Memorial Antalya Hastanesi, Antalya, Not set
Okmeydani Research and Training Hospital, Istanbul, Not set
Istanbul University Cerrahpasa Medical Faculty, Istanbul, Not set
Bakirkoy Dr. Sadi Konuk Teaching and Research Hospital, Istanbul, Not set
Medipol University Medical Faculty, Istanbul, Not set
Kartal Lutfi Kirdar Research and Training Hospital, Istanbul, Not set
Ege University Medical Faculty, Izmir, Not set
Inonu Uni. Med. Fac., Malatya, Not set
Mersin University Medical Faculty, Mersin, Not set
Sakarya Traning and Research Hospital, Sakarya, Not set
Namik Kemal University, Tekirdag, Not set
CI Chernivtsi RC Oncological Dispensary Bukovinian SMU Ch of Oncology and Radiology, Chernivtsi, Not set
CI Dnipropetrovsk CMCH #4 of Dnipropetrovsk RC Dept of Chemotherapy SI Dnipropetrovsk MA of MOHU, Dnipro, Not set
CI Transcarpathian Cl Onc Center Dep of Surgery#1 SHEI Ivano-Frankivsk NMU, Ivano-Frankivsk, Not set
SI S.P.Grygoriev Institute of Medical Radiology of NAMSU, Kharkiv, Not set
Communal Non-profit Enterprise Regional Center of Oncology, Kharkiv, Not set
Kherson Regional Oncologic Dispensary, Kherson, Not set
Treatment-Diagnostic Center of Private Enterprise of PPC Atsynus, Kropyvnytskyi, Not set
CI Kryvyi Rih Oncological Dispensary of DRC, Kryvyi Rih, Dnipropetrovsk Region, Not set
Kyiv City Clinical Oncological Center, Kyiv, Not set
Treatment-Prevention Institution Volyn Regional Oncological Dispensary, Lutsk, Not set
Lviv State Oncological Regional Treatment and Diagnostic Center, Lviv, Not set
Odesa Regional Oncologic Dispensary, Odesa, Not set
RCI Sumy Regional Clinical Oncological Dispensary, Sumy, Not set
CCCH City Oncological Center SHEI Uzhgorod NU, Uzhgorod, Not set
Podilskyi Regional Oncological Center, Vinnytsia, Not set
Vinnytsia Regional Clinical Oncological Dispensary, Vinnytsia, Not set
Southend University Hospital, Westcliff on Sea, Essex
Cheltenham General Hospital, Cheltenham, Gloucestershire
Chelsea and Westminster Hospital, London, Greater London
Mount Vernon Hospital, Stevenage, Hertfordshire
The Clatterbridge Cancer Centre, Wirral, Merseyside
Royal Stoke University Hospital, Stoke on Trent, Staffordshire
Conditions: First Line Non-Small Cell Lung Cancer
A Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid Tumors
Active Not Recruiting
An open-label, dose-escalation (Part 1), dose-expansion (Part 2) study to assess the safety, pharmacokinetics (PK), and preliminary efficacy of ABBV-155 alone and in combination with paclitaxel or docetaxel.
In Part 1 (dose escalation), participants will receive escalating doses of ABBV-155 monotherapy (Part 1a) or ABBV-155 in combination with paclitaxel or docetaxel (Part 1b).
In Part 2 (dose expansion), participants will receive ABBV-155 monotherapy or in combination therapy. The ABBV-155 mo... Read More
An open-label, dose-escalation (Part 1), dose-expansion (Part 2) study to assess the safety, pharmacokinetics (PK), and preliminary efficacy of ABBV-155 alone and in combination with paclitaxel or docetaxel.
In Part 1 (dose escalation), participants will receive escalating doses of ABBV-155 monotherapy (Part 1a) or ABBV-155 in combination with paclitaxel or docetaxel (Part 1b).
In Part 2 (dose expansion), participants will receive ABBV-155 monotherapy or in combination therapy. The ABBV-155 monotherapy cohort will enroll participants with relapsed or refractory (R/R) small cell lung cancer (SCLC) (Part 2a); the ABBV-155 plus a taxane (paclitaxel or docetaxel) combination cohort will enroll participants with R/R non-small cell lung cancer (NSCLC) and breast cancer (Part 2b). Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/16/2025
Locations: University of Alabama at Birmingham - Main /ID# 214024, Birmingham, Alabama +39 locations
University of Alabama at Birmingham - Main /ID# 214024, Birmingham, Alabama
Highlands Oncology Group, PA /ID# 201568, Springdale, Arkansas
UC Irvine Medical Center - Chao Family Comprehensive Cancer Center /ID# 206105, Orange, California
Duplicate_Cedars-Sinai Medical Center-West Hollywood /ID# 204267, West Hollywood, California
Univ of Colorado Cancer Center /ID# 208365, Aurora, Colorado
Yale University, Yale Cancer Center /ID# 201542, New Haven, Connecticut
AdventHealth Orlando /ID# 227242, Orlando, Florida
Northwestern University Feinberg School of Medicine /ID# 201563, Chicago, Illinois
Johns Hopkins Bayview Med Cnt /ID# 215095, Baltimore, Maryland
Johns Hopkins Hospital /ID# 201320, Baltimore, Maryland
Dana-Farber Cancer Institute /ID# 201564, Boston, Massachusetts
Duplicate_Henry Ford Hospital /ID# 226852, Detroit, Michigan
Northwell Health - Marcus Ave /ID# 204376, New Hyde Park, New York
Carolina BioOncology Institute /ID# 201577, Huntersville, North Carolina
Univ Hosp Cleveland /ID# 201567, Cleveland, Ohio
University of Oklahoma, Stephenson Cancer Center /ID# 206820, Oklahoma City, Oklahoma
Lifespan Cancer Institute at Rhode Island Hospital /ID# 204256, Providence, Rhode Island
Vanderbilt Ingram Cancer Center /ID# 201575, Nashville, Tennessee
Mary Crowley Cancer Research /ID# 214168, Dallas, Texas
MD Anderson Cancer Center /ID# 201558, Houston, Texas
NEXT Oncology /ID# 204893, San Antonio, Texas
Peter MacCallum Cancer Center /ID# 241676, Melbourne, New South Wales
Cross Cancer Institute /ID# 213838, Edmonton, Alberta
University Health Network_Princess Margaret Cancer Centre /ID# 204539, Toronto, Ontario
Rambam Health Care Campus /ID# 230813, Haifa, H_efa
The Chaim Sheba Medical Center /ID# 230812, Ramat Gan, Tel-Aviv
National Cancer Center Hospital East /ID# 215130, Kashiwa-shi, Chiba
National Cancer Center Hospital /ID# 215003, Chuo-ku, Tokyo
National Cancer Center /ID# 241095, Goyang-si, Gyeonggido
Yonsei University Health System Severance Hospital /ID# 240648, Seoul, Not set
Maastricht Universitair Medisch Centrum /ID# 225220, Maastricht, Limburg
Antoni van Leeuwenhoek /ID# 222260, Amsterdam, Noord-Holland
Erasmus Medisch Centrum /ID# 222341, Rotterdam, Zuid-Holland
Universitair Medisch Centrum Utrecht /ID# 222357, Utrecht, Not set
Pan American Center for Oncology Trials, LLC /ID# 232128, Rio Piedras, Not set
Hospital Universitario Fundacion Jimenez Diaz /ID# 239997, Madrid, Not set
Hospital Universitario 12 de Octubre /ID# 239999, Madrid, Not set
National Taiwan University Hospital /ID# 205673, Taipei City, Taipei
China Medical University Hospital /ID# 214062, Taichung, Not set
National Cheng Kung University Hospital /ID# 206304, Tainan, Not set
Conditions: Advanced Solid Tumors
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
Completed
The purpose of this neoadjuvant study is to compare nivolumab plus chemotherapy and chemotherapy alone in terms of safety and effectiveness, and to describe nivolumab plus ipilimumab's safety and effectiveness in treating resectable NSCLC.
This study has multiple primary endpoints.
The purpose of this neoadjuvant study is to compare nivolumab plus chemotherapy and chemotherapy alone in terms of safety and effectiveness, and to describe nivolumab plus ipilimumab's safety and effectiveness in treating resectable NSCLC.
This study has multiple primary endpoints. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/13/2025
Locations: Local Institution - 0121, Glendale, Arizona +139 locations
Local Institution - 0121, Glendale, Arizona
Local Institution - 0081, Los Angeles, California
Local Institution - 0025, Denver, Colorado
Local Institution - 0007, Plainville, Connecticut
Local Institution - 0173, Hollywood, Florida
Local Institution - 0136, Miami, Florida
Local Institution - 0054, Orlando, Florida
Orlando Health, Inc., Orlando, Florida
Indian River Medical Center, Vero Beach, Florida
Northwest Georgia Oncology Center, P.C., Marietta, Georgia
Local Institution - 0015, Chicago, Illinois
Local Institution - 0002, Chicago, Illinois
Illinois Cancer Specialists, Niles, Illinois
Local Institution - 0171, Fort Wayne, Indiana
Local Institution - 0170, Lexington, Kentucky
Local Institution - 0186, Louisville, Kentucky
University Medical Center New Orleans, New Orleans, Louisiana
Local Institution - 0151, Baltimore, Maryland
Local Institution - 0001, Baltimore, Maryland
Local Institution - 0008, Boston, Massachusetts
Southcoast Center For Cancer, Fairhaven, Massachusetts
Local Institution - 0006, Newton, Massachusetts
Local Institution - 0012, Detroit, Michigan
Local Institution - 0090, Hattiesburg, Mississippi
St Vincent Frontier Cancer Center, Billings, Montana
Local Institution - 0032, Las Vegas, Nevada
Local Institution - 0009, Hackensack, New Jersey
Valley Hospital Luckow Pavili, Westwood, New Jersey
Local Institution - 0027, Albany, New York
Local Institution - 0011, New York, New York
Local Institution - 0140, High Point, North Carolina
Christ Hospital, Cincinnati, Ohio
MetroHealth Medical Center, Cleveland, Ohio
Local Institution - 0149, Zanesville, Ohio
Kaiser Permanente, Portland, Oregon
Local Institution - 0139, Portland, Oregon
Local Institution - 0010, Philadelphia, Pennsylvania
Local Institution - 0018, Pittsburgh, Pennsylvania
Local Institution - 0013, Charleston, South Carolina
Local Institution - 0021, Charleston, South Carolina
Local Institution - 0146, Greenville, South Carolina
Local Institution - 0092, Nashville, Tennessee
Local Institution - 0005, Nashville, Tennessee
Local Institution - 0035, Austin, Texas
Texas Oncology, Bedford, Texas
Local Institution - 0153, Fort Bliss, Texas
Local Institution - 0106, Houston, Texas
Southwest Cancer Center, Lubbock, Texas
Texas Cancer Center - Sherman, Sherman, Texas
Local Institution - 0143, Tyler, Texas
Local Institution - 0026, Waco, Texas
Intermountain Medical Center, Murray, Utah
Southwest Regional Cancer Clinic, Saint George, Utah
Local Institution - 0003, Salt Lake City, Utah
Local Institution - 0135, Burlington, Vermont
Local Institution - 0125, Fairfax, Virginia
Local Institution - 0198, Fredericksburg, Virginia
Local Institution - 0022, Capital Federal, Buenos Aires
Local Institution - 0023, Ciudad Autonoma De Buenos Aire, Buenos Aires
Local Institution - 0079, Brasilia, Distrito Federal
Local Institution - 0077, Belo Horizonte, Minas Gerais
Local Institution - 0076, Ijui, RIO Grande DO SUL
Local Institution - 0073, Porto Alegre, RIO Grande DO SUL
Fundacao Pio Xii Hosp Cancer De Barretos, Barretos, Sao Paulo
Local Institution - 0075, Rio de Janeiro, Not set
Local Institution - 0095, Gatineau, Quebec
Local Institution - 0138, Montreal, Quebec
Local Institution - 0017, Montreal, Quebec
Local Institution - 0052, Trois-Rivieres, Quebec
Local Institution - 0016, Saskatoon, Saskatchewan
Local Institution - 0161, Beijing, Beijing
Local Institution, Beijing, Beijing
Local Institution - 0156, Beijing, Beijing
Local Institution - 0190, Guangzhou, Guangdong
Local Institution - 0192, Changsha, Hunan
Local Institution - 0175, Changsha, Hunan
Local Institution - 0193, Changsha, Hunan
Local Institution - 0179, Nanchang, Jiangxi
Local Institution - 0166, Nanchang, Jiangxi
Local Institution, Changchun, Jilin
Local Institution - 0159, XiAn, Shan1xi
Local Institution - 0180, Xian, Shan3xi
Local Institution - 0160, Shanghai, Shanghai
Local Institution - 0178, Chengdu, Sichuan
Local Institution - 0163, Tianjin, Tianjin
Local Institution - 0189, Hangzhou, Zhejiang
Local Institution - 0183, Hangzhou, Zhejiang
Local Institution - 0182, Hangzhou, Zhejiang
Local Institution - 0165, Shanghai, Not set
Local Institution - 0059, Marseille Cedex 20, Not set
Local Institution - 0112, Paris Cedex 5, Not set
Local Institution - 0060, Paris, Not set
Local Institution - 0064, Pierre Benite Cedax, Not set
Local Institution - 0061, Rennes Cedex 9, Not set
Local Institution - 0113, Strasbourg, Not set
Local Institution - 0058, Toulouse, Not set
Local Institution - 0062, Tours Cedex 09, Not set
Local Institution - 0019, Athens, Not set
Local Institution - 0122, Thessaloniki, Not set
Local Institution, Budapest, Not set
Local Institution, Szekesfehervar, Not set
Local Institution - 0068, Bari, Not set
Local Institution - 0080, Genova, Not set
Local Institution - 0070, Perugia, Not set
Local Institution - 0066, Ravenna, Not set
Local Institution - 0067, Roma, Not set
Local Institution - 0131, Nagoya-shi, Aichi
Local Institution - 0118, Kashiwa-shi, Chiba
Local Institution - 0111, Kitakyushu-shi, Fukuoka
Local Institution - 0110, Fukushima-shi, Fukushima
Local Institution - 0109, Hiroshima-Shi, Hiroshima
Local Institution - 0147, Sapporo-shi, Hokkaido
Local Institution - 0133, Kobe-shi, Hyogo
Local Institution - 0123, Yokohama-shi, Kanagawa
Local Institution - 0148, Sendai-shi, Miyagi
Local Institution - 0127, Osaka-shi, Osaka
Local Institution - 0119, Sakai-shi, Osaka
Local Institution - 0132, Sunto-gun, Shizuoka
Local Institution - 0126, Bunkyo-ku, Tokyo
Local Institution - 0120, Shinjuku-ku, Tokyo
Local Institution - 0108, Osaka, Not set
Local Institution - 0124, Tokyo, Not set
Local Institution - 0097, Busan, Not set
Local Institution - 0098, Hwasun, Not set
Local Institution - 0105, Seoul, Not set
Local Institution - 0042, Amsterdam, Not set
Local Institution - 0043, Groningen, Not set
Local Institution - 0050, Craiova, Not set
Local Institution - 0051, Romania, Not set
Local Institution - 0069, Sector 2, Not set
Local Institution - 0028, Barcelona, Not set
Local Institution - 0029, Madrid, Not set
Local Institution - 0031, Majadahonda - Madrid, Not set
Local Institution - 0102, New Taipei City, Not set
Local Institution - 0107, Taichung, Not set
Local Institution - 0099, Taipei, Not set
Local Institution - 0100, Taipei, Not set
Local Institution - 0093, Adana, Not set
Local Institution - 0084, Ankara, Not set
Local Institution - 0115, Istanbul, Not set
Conditions: Non Small Cell Lung Cancer
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-522/KEYNOTE-522)
Active Not Recruiting
The purpose of this study is to evaluate the efficacy and safety of pembrolizumab (MK-3475) plus chemotherapy vs placebo plus chemotherapy as neoadjuvant therapy and pembrolizumab vs placebo as adjuvant therapy in participants who have triple negative breast cancer (TNBC).
After a screening phase of approximately 28 days, each participant will receive neoadjuvant study treatment (Pembrolizumab + Chemotherapy OR Placebo + Chemotherapy) based on the randomization schedule for approximately 24 wee... Read More
The purpose of this study is to evaluate the efficacy and safety of pembrolizumab (MK-3475) plus chemotherapy vs placebo plus chemotherapy as neoadjuvant therapy and pembrolizumab vs placebo as adjuvant therapy in participants who have triple negative breast cancer (TNBC).
After a screening phase of approximately 28 days, each participant will receive neoadjuvant study treatment (Pembrolizumab + Chemotherapy OR Placebo + Chemotherapy) based on the randomization schedule for approximately 24 weeks (8 cycles). Each participant will then undergo definitive surgery 3-6 weeks after conclusion of the last cycle of the neoadjuvant study treatment. After definitive surgery, each participant will receive adjuvant study treatment (Pembrolizumab OR Placebo) for approximately 27 weeks (9 cycles). Following adjuvant study treatment, each participant will be monitored for safety, survival and disease recurrence.
The primary study hypothesis is that pembrolizumab is superior to placebo, in combination with chemotherapy, as measured by the rate of Pathological Complete Response (pCR) and/or Event-free Survival (EFS), in participants with locally advanced TNBC. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/08/2025
Locations: Virginia G. Piper Cancer Center Pharmacy - Scottsdale Healthcare ( Site 0089), Scottsdale, Arizona +192 locations
Virginia G. Piper Cancer Center Pharmacy - Scottsdale Healthcare ( Site 0089), Scottsdale, Arizona
Arizona Oncology Associates PC- HOPE ( Site 8001), Tucson, Arizona
Cedars Sinai Medical Center ( Site 0091), Los Angeles, California
Pacific Cancer Care ( Site 0069), Monterey, California
ICRI ( Site 0072), Whittier, California
University of Colorado Cancer Center ( Site 0021), Aurora, Colorado
Yale University School of Medicine ( Site 0054), New Haven, Connecticut
Christiana Hospital ( Site 0029), Newark, Delaware
Univ of Miami-Sylvester Comprehensive Cancer Center- Kendall satellite ( Site 0079), Miami, Florida
The University of Chicago Medical Center ( Site 0047), Chicago, Illinois
North Shore University Health System ( Site 0081), Evanston, Illinois
Orchard Healthcare Research Inc. ( Site 0049), Skokie, Illinois
Goshen Center for Cancer Care ( Site 0010), Goshen, Indiana
University of Iowa Hospital and Clinics ( Site 0038), Iowa City, Iowa
New England Cancer Specialists ( Site 0005), Scarborough, Maine
Henry Ford Hospital ( Site 0003), Detroit, Michigan
Minnesota Oncology Hematology, PA ( Site 8013), Minneapolis, Minnesota
Rutgers Cancer Institute of New Jersey ( Site 0073), New Brunswick, New Jersey
Broome Oncology, LLC ( Site 8002), Johnson City, New York
Nyack Hospital Infusion Center ( Site 0059), Nyack, New York
TriHealth Cancer Institute-Good Samaritan Hospital ( Site 0044), Cincinnati, Ohio
Oncology Hematology Care, Inc. ( Site 8011), Cincinnati, Ohio
Providence Portland Medical Center ( Site 0052), Portland, Oregon
Northwest Cancer Specialists, P.C. ( Site 8008), Portland, Oregon
Magee - Women's Hospital ( Site 0011), Pittsburgh, Pennsylvania
Rhode Island Hospital ( Site 0060), Providence, Rhode Island
The West Clinic, P.C. ( Site 0078), Germantown, Tennessee
Texas Oncology-Austin Central ( Site 8005), Austin, Texas
Parkland Health and Hospital System ( Site 0093), Dallas, Texas
Texas Oncology-Baylor Charles A. Sammons Cancer Center ( Site 8006), Dallas, Texas
Simmons Cancer Center ( Site 0094), Dallas, Texas
UT Southwestern Medical Center ( Site 0030), Dallas, Texas
Moncrief Cancer Institute ( Site 0092), Fort Worth, Texas
Texas Oncology-Memorial City ( Site 8003), Houston, Texas
Houston Methodist Cancer Center ( Site 0013), Houston, Texas
Texas Oncology- Plano East ( Site 8010), Plano, Texas
Texas Oncology-San Antonio Northeast ( Site 8012), San Antonio, Texas
Texas Oncology-Tyler ( Site 8007), Tyler, Texas
University of Virginia ( Site 0022), Charlottesville, Virginia
Virginia Cancer Specialists, PC ( Site 8009), Fairfax, Virginia
Bon Secours Cancer Institute Medical Oncology at St. Mary's ( Site 0033), Midlothian, Virginia
Peninsula Cancer Institute, LLC ( Site 0041), Newport News, Virginia
Virginia Oncology Associates ( Site 8000), Norfolk, Virginia
Kadlec Clinic Hematology and Oncology ( Site 0087), Kennewick, Washington
Seattle Cancer Care Alliance ( Site 0068), Seattle, Washington
Medical Oncology Associates (Summit Cancer Centers) ( Site 0014), Spokane, Washington
YVMH dba Vrigina Mason Memorial/North Star Lodge Cancer Center ( Site 8004), Yakima, Washington
Royal North Shore Hospital ( Site 2000), Sydney, New South Wales
Westmead Hospital ( Site 2002), Sydney, New South Wales
Royal Adelaide Hospital ( Site 2008), Adelaide, South Australia
Cabrini Health ( Site 2009), East Malvern, Victoria
Frankston Hospital ( Site 2010), Franskton, Not set
Royal Brisbane and Women s Hospital ( Site 2003), Herston, Not set
St John of God Subiaco Hospital ( Site 2006), Perth, Not set
Hospital Nossa Senhora da Conceicao ( Site 0203), Porto Alegre, Rio Grande Do Sul
UOPECCAN - Uniao Oeste Paranaense de Estudos e Combate ao Cancer ( Site 0206), Cascavel, Not set
Universidade de Caxias do Sul ( Site 0201), Caxias do Sul, Not set
Hospital Erasto Gaertner ( Site 0207), Curitiba, Not set
Instituto do Cancer do Ceara ( Site 0205), Fortaleza, Not set
Hospital Araujo Jorge ( Site 0204), Goiania, Not set
Hospital Sao Lucas da PUCRS ( Site 0200), Porto Alegre, Not set
Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto ( Site 0208), Sao Jose do Rio Preto, Not set
Instituto do Cancer de Sao Paulo - ICESP ( Site 0211), Sao Paulo, Not set
Tom Baker Cancer Centre ( Site 0105), Calgary, Alberta
The Ottawa Hospital - Cancer Care ( Site 0100), Ottawa, Ontario
Princess Margaret Cancer Centre ( Site 0103), Toronto, Ontario
Centre Hospitalier de l Universite de Montreal - CHUM ( Site 0106), Montreal, Quebec
Jewish General Hospital ( Site 0101), Montreal, Quebec
CIUSSS de l'Estrie-CHUS ( Site 0102), Sherbrooke, Quebec
CHU de Quebec Universite Laval - Hopital du Saint-Sacrement ( Site 0104), Quebec, Not set
Oncomedica S.A. ( Site 0404), Monteria, Cordoba
Oncologos del Occidente S.A. ( Site 0405), Pereira, Risaralda
Hospital Universitario San Ignacio ( Site 0401), Bogota, Not set
Instituto Nacional de Cancerologia [Bogota-Colombia] ( Site 0403), Bogota, Not set
Hemato Oncologos S.A. ( Site 0400), Cali, Not set
Instituto De Cancerologia S.A. ( Site 0406), Medellin, Not set
CHU Jean Minjoz ( Site 0917), Besancon, Not set
Polyclinique Bordeaux Nord Aquitaine ( Site 0911), Bordeaux, Not set
Centre Francois Baclesse ( Site 0907), Caen, Not set
Centre Jean Perrin ( Site 0903), Clermont-Ferrand Cedex 01, Not set
Clinique Victor Hugo ( Site 0901), Le Mans, Not set
Hopital prive du Confluent ( Site 0902), Nantes, Not set
Institut Curie ( Site 0909), Paris, Not set
Hopital Saint Louis ( Site 0908), Paris, Not set
Hopital Diaconesses Croix Saint Simon ( Site 0905), Paris, Not set
CHU de la Miletrie Poitiers ( Site 0913), Poitiers, Not set
Institut Claudius Regaud IUCT Oncopole ( Site 0914), Toulouse Cedex 9, Not set
HELIOS Klinikum Berlin-Buch ( Site 1005), Berlin, Not set
Gynaekologisches Zentrum ( Site 1004), Bonn, Not set
Universitaetsklinikum Erlangen ( Site 1001), Erlangen, Not set
Kliniken Essen Mitte ( Site 1012), Essen, Not set
Universitaetsklinik und Poliklinik Halle/Saale ( Site 1008), Halle, Not set
Universitaetsklinikum Hamburg-Eppendorf ( Site 1007), Hamburg, Not set
Klinikum der Universit. Muenchen ( Site 1002), Muenchen, Not set
Caritasklinik St. Theresia ( Site 1011), Saarbruecken, Not set
Universitaets-Frauenklinik Tuebingen ( Site 1003), Tubingen, Not set
Bon Secours Hospital ( Site 1551), Cork, Not set
St Vincents University Hospital ( Site 1550), Dublin, Not set
Oncology institute ( Site 1601), Beer Sheva, Not set
Assaf Harofeh MC ( Site 1605), Beer Yaakov-Zerifin, Not set
Hadassah Ein Karem - Sharett Institute of Oncology ( Site 1600), Jerusalem, Not set
Rabin-Medical Center ( Site 1604), Petah Tikva, Not set
Sheba Medical Center ( Site 1602), Ramat-Gan, Not set
Sourasky Medical Center ( Site 1603), Tel Aviv, Not set
Istituto Scientifico Romagnolo per Studio e Cura Tumori IRST ( Site 1101), Meldola, FC
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia ( Site 1103), Brescia, Not set
Ospedale San Luca, AZIENDA USL2 TOSCANA NORD OVEST ( Site 1105), Lucca, Not set
Ospedale Civile di Macerata ( Site 1104), Macerata, Not set
Istituto Europeo di Oncologia ( Site 1106), Milano, Not set
Istituto Nazionale Tumori IRCCS Fondazione Pascale ( Site 1102), Napoli, Not set
Aichi Cancer Center Hospital ( Site 2502), Nagoya, Aichi
National Cancer Center Hospital East ( Site 2518), Kashiwa, Chiba
National Hospital Organization Hokkaido Cancer Center ( Site 2512), Sapporo, Hokkaido
Hyogo College of Medicine Hospital ( Site 2506), Nishinomiya, Hyogo
Tokai University Hospital ( Site 2517), Isehara, Kanagawa
St. Marianna University School of Medicine Hospital ( Site 2516), Kawasaki, Kanagawa
Kindai University Hospital ( Site 2507), Osakasayama, Osaka
Saitama Medical University International Medical Center ( Site 2513), Hidaka, Saitama
Saitama Cancer Center ( Site 2510), Kitaadachi-gun, Saitama
Shizuoka Cancer Center Hospital and Research Institute ( Site 2514), Sunto-gun, Shizuoka
Chiba Cancer Center ( Site 2519), Chiba, Not set
Hiroshima City Hiroshima Citizens Hospital ( Site 2501), Hiroshima, Not set
Social medical corporation Hakuaikai Sagara Hospital ( Site 2508), Kagoshima, Not set
Kumamoto University Hospital ( Site 2515), Kumamoto, Not set
National Hospital Organization Osaka National Hospital ( Site 2505), Osaka, Not set
National Cancer Center Hospital ( Site 2500), Tokyo, Not set
St.Luke's International Hospital ( Site 2511), Tokyo, Not set
Toranomon Hospital ( Site 2503), Tokyo, Not set
The Cancer Institute Hospital of JFCR ( Site 2509), Tokyo, Not set
Seoul National University Hospital ( Site 2101), Seoul, Not set
Severance Hospital Yonsei University Health System ( Site 2100), Seoul, Not set
Asan Medical Center ( Site 2102), Seoul, Not set
Samsung Medical Center ( Site 2103), Seoul, Not set
Mazowiecki Szpital Onkologiczny ( Site 1713), Wieliszew, Mazowieckie
Centrum Onkologii Instytut im. Marii Skłodowskiej Curie ( Site 1717), Gliwice, Slaskie
Centrum Onkologii im. Prof. Franciszka Lukaszczyka ( Site 1708), Bydgoszcz, Not set
Centrum Onkologii im. Prof. Franciszka Lukaszczyka ( Site 1712), Bydgoszcz, Not set
Szpital Morski im. PCK. Szpitale Pomorskie Sp. Z o.o ( Site 1701), Gdynia, Not set
Centrum Onkologii Instytut im. Marii Sklodowskiej Curie ( Site 1719), Krakow, Not set
Centrum Onkologii Ziemi Lubelskiej im. sw. Jana z Dukli ( Site 1700), Lublin, Not set
Dolnoslaskie Centrum Onkologii. ( Site 1702), Wroclaw, Not set
Fundacao Champalimaud ( Site 2444), Lisboa, Not set
Hospital de Santa Maria, E.P.E. ( Site 2445), Lisboa, Not set
Instituto Portugues de Oncologia Do Porto Francisco Gentil E.P.E. ( Site 2446), Porto, Not set
Arkhangelsk Clinical Oncological Dispensary ( Site 1810), Arkhangelsk, Not set
Chelyabinsk Regional Clinical Oncological Dispensary ( Site 1805), Chelyabinsk, Not set
Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 1806), Kazan, Not set
Russian Oncological Research Center n.a. N.N.Blokhin of MoH ( Site 1801), Moscow, Not set
GBU RO Regional Clinical Oncological Dispensary ( Site 1808), Ryazan, Not set
Scientific Research Oncology Institute n.a. N.N.Petrov ( Site 1803), Saint Petersburg, Not set
Republican Clinical Oncology Dispensary of Republic of Bashkortostan ( Site 1804), Ufa, Not set
National Cancer Centre Singapore ( Site 2600), Singapore, Not set
ICO L Hospitalet ( Site 1305), Hospitalet de Llobregat, Barcelona
Hospital Quiron de Madrid ( Site 1303), Pozuelo de Alarcon, Madrid
Hospital del Mar ( Site 1306), Barcelona, Not set
Instituto Oncologico Baselga.Hospital Quiron. ( Site 1312), Barcelona, Not set
Hospital General Universitari Vall d Hebron ( Site 1301), Barcelona, Not set
Hospital Universitario Reina Sofia ( Site 1304), Cordoba, Not set
Hospital Universitario Ramon y Cajal ( Site 1300), Madrid, Not set
Complejo Hospitalario Universitario de Santiago ( Site 1308), Santiago de Compostela, Not set
Hospital Universitario Virgen del Rocio ( Site 1314), Sevilla, Not set
Hospital Clinico Univ de Valencia ( Site 1313), Valencia, Not set
Linkopings Universitetssjukhus ( Site 1402), Linkoping, Not set
Karolinska Universitetssjukhuset Solna ( Site 1404), Solna, Not set
Norrlands Universitetssjukhus ( Site 1401), Umea, Not set
Akademiska Sjukhuset ( Site 1403), Uppsala, Not set
Taipei Veterans General Hospital ( Site 2302), Taipei, Beitou
National Cheng Kung University Hospital ( Site 2305), Tainan, Not set
National Taiwan University Hospital ( Site 2301), Taipei, Not set
MacKay Memorial Hospital ( Site 2303), Taipei, Not set
Koo Foundation Sun Yat-Sen Cancer Center ( Site 2304), Taipei, Not set
Linkou Chang Gung Memorial Hospital ( Site 2300), Taoyuan, Not set
Samsun Ondokuz Mayıs Universitesi Tıp Fakultesi Hastanesi ( Site 1910), Samsun, Atakum
Adana Acıbadem Hospital Department of Medical Oncology ( Site 1906), Adana, Not set
Baskent Unıversity Adana Kısla Hospital ( Site 1903), Adana, Not set
Hacettepe Universitesi Tip Fakultesi Hastanesi ( Site 1912), Ankara, Not set
Abdurrahman Yurtaslan Oncology Training and Research Hospital ( Site 1909), Ankara, Not set
Ozel Medicana International Ankara Hastanesi ( Site 1915), Ankara, Not set
Antalya Memorial Hospital Department of Medical Oncology ( Site 1908), Antalya, Not set
Trakya University Medical Faculty Balkan Oncology Hospital ( Site 1901), Edirne, Not set
Acibadem Altunizade Hastanesi ( Site 1900), Istambul, Not set
İstanbul University Cerrahpaşa Medical Faculty ( Site 1904), Istanbul, Not set
Amerikan Hospital Medical ( Site 1902), Istanbul, Not set
Memorial Sisli Hastanesi ( Site 1913), Istanbul, Not set
Ege University Medical Faculty Tulay Aktas Oncology Hospital ( Site 1905), Izmir, Not set
Izmir Medical Park Hospital Department of Medical Oncology ( Site 1907), Izmir, Not set
Colchester General Hospital ( Site 1508), Colchester, Essex
Barts Cancer Institute ( Site 1500), London, Not set
St George s Hospital ( Site 1516), London, Not set
Maidstone Hospital ( Site 1511), Maidstone, Not set
The James Cook University Hospital ( Site 1515), Middlesbrough, Not set
Nottingham University Hospitals NHS Trust ( Site 1505), Nottingham, Not set
Royal Cornwall Hospitals NHS Trust ( Site 1504), Truro, Not set
Conditions: Triple Negative Breast Neoplasms
Study of Efficacy and Safety of NIS793 in Combination With Standard of Care (SOC) Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) - daNIS-2
Completed
The purpose of this study is to evaluate the efficacy and safety of NIS793 in combination with gemcitabine/nab-paclitaxel versus gemcitabine/nab-paclitaxel and placebo in first-line metastatic pancreatic ductal adenocarcinoma (mPDAC).
This study aims to explore whether blockade of Transforming Growth Factor β (TGFβ) in combination with gemcitabine/nab-paclitaxel can reduce fibrosis in PDAC, restore chemo-sensitivity and ultimately lead to improvements in overall survival (OS) and other clinical... Read More
The purpose of this study is to evaluate the efficacy and safety of NIS793 in combination with gemcitabine/nab-paclitaxel versus gemcitabine/nab-paclitaxel and placebo in first-line metastatic pancreatic ductal adenocarcinoma (mPDAC).
This study aims to explore whether blockade of Transforming Growth Factor β (TGFβ) in combination with gemcitabine/nab-paclitaxel can reduce fibrosis in PDAC, restore chemo-sensitivity and ultimately lead to improvements in overall survival (OS) and other clinically relevant outcomes. Read Less
Gender:
ALL
Ages:
Between 18 years and 100 years
Trial Updated:
01/06/2025
Locations: Highlands Oncology Group, Fayetteville, Arkansas +112 locations
Highlands Oncology Group, Fayetteville, Arkansas
University of California LA, Los Angeles, California
Advent Health Cancer Institute, Orlando, Florida
Fort Wayne Medical Oncology Hematology Inc, Fort Wayne, Indiana
NYU Clinical Cancer Center, New York, New York
US Oncology Research Dallas, Dallas, Texas
Houston Methodist Hospital, Houston, Texas
Huntsman Cancer Institute, Salt Lake City, Utah
Seattle Cancer Care Alliance, Seattle, Washington
Novartis Investigative Site, Adelaide, South Australia
Novartis Investigative Site, Perth, Western Australia
Novartis Investigative Site, Bonheiden, Not set
Novartis Investigative Site, Bruxelles, Not set
Novartis Investigative Site, Edegem, Not set
Novartis Investigative Site, Leuven, Not set
Novartis Investigative Site, Brasilia, Distrito Federal
Novartis Investigative Site, Porto Alegre, Rio Grande Do Sul
Novartis Investigative Site, Ijui, RS
Novartis Investigative Site, Sao Paulo, SP
Novartis Investigative Site, Brampton, Ontario
Novartis Investigative Site, Cambridge, Ontario
Novartis Investigative Site, Toronto, Ontario
Novartis Investigative Site, Guangzhou, Guangdong
Novartis Investigative Site, Harbin, Heilongjiang
Novartis Investigative Site, Nanjing, Jiangsu
Novartis Investigative Site, Dalian, Liaoning
Novartis Investigative Site, Jining, Shandong
Novartis Investigative Site, Xian, Shanxi
Novartis Investigative Site, Chengdu, Sichuan
Novartis Investigative Site, Hangzhou, Zhejiang
Novartis Investigative Site, Beijing, Not set
Novartis Investigative Site, Beijing, Not set
Novartis Investigative Site, Beijing, Not set
Novartis Investigative Site, Shanghai, Not set
Novartis Investigative Site, Shanghai, Not set
Novartis Investigative Site, Shanghai, Not set
Novartis Investigative Site, Shanghai, Not set
Novartis Investigative Site, Tianjin, Not set
Novartis Investigative Site, Brno, Czech Republic
Novartis Investigative Site, Novy Jicin, Czech Republic
Novartis Investigative Site, Hradec Kralove, CZE
Novartis Investigative Site, Praha 4, Not set
Novartis Investigative Site, Helsinki, Not set
Novartis Investigative Site, Tampere, Not set
Novartis Investigative Site, Nice, Alpes Maritimes
Novartis Investigative Site, Avignon, Not set
Novartis Investigative Site, Besancon Cedex, Not set
Novartis Investigative Site, Creteil, Not set
Novartis Investigative Site, Lyon 08, Not set
Novartis Investigative Site, Marseille, Not set
Novartis Investigative Site, Montpellier, Not set
Novartis Investigative Site, Nantes Cedex 1, Not set
Novartis Investigative Site, Paris, Not set
Novartis Investigative Site, Berlin, Not set
Novartis Investigative Site, Bochum, Not set
Novartis Investigative Site, Essen, Not set
Novartis Investigative Site, Frankfurt, Not set
Novartis Investigative Site, Halle S, Not set
Novartis Investigative Site, Hamburg, Not set
Novartis Investigative Site, Ulm, Not set
Novartis Investigative Site, Thessaloniki, Not set
Novartis Investigative Site, Thessaloniki, Not set
Novartis Investigative Site, Budapest, Not set
Novartis Investigative Site, Budapest, Not set
Novartis Investigative Site, Debrecen, Not set
Novartis Investigative Site, Jerusalem, Not set
Novartis Investigative Site, Ramat Gan, Not set
Novartis Investigative Site, Tel Aviv, Not set
Novartis Investigative Site, Firenze, FI
Novartis Investigative Site, Milano, MI
Novartis Investigative Site, Milano, MI
Novartis Investigative Site, Verona, VR
Novartis Investigative Site, Nagoya, Aichi
Novartis Investigative Site, Kashiwa, Chiba
Novartis Investigative Site, Yokohama-city, Kanagawa
Novartis Investigative Site, Osaka-city, Osaka
Novartis Investigative Site, Chuo ku, Tokyo
Novartis Investigative Site, Koto ku, Tokyo
Novartis Investigative Site, Seoul, Seocho Gu
Novartis Investigative Site, Seoul, Not set
Novartis Investigative Site, Seoul, Not set
Novartis Investigative Site, Utrecht, Not set
Novartis Investigative Site, Nordbyhagen, Oslo
Novartis Investigative Site, Oslo, Not set
Novartis Investigative Site, Omsk, Not set
Novartis Investigative Site, Pushkin Saint Petersburg, Not set
Novartis Investigative Site, Singapore, Not set
Novartis Investigative Site, Bratislava, Slovak Republic
Novartis Investigative Site, Banska Bystrica, Not set
Novartis Investigative Site, Kosice, Not set
Novartis Investigative Site, Barcelona, Catalunya
Novartis Investigative Site, Hospitalet de LLobregat, Catalunya
Novartis Investigative Site, Santiago De Compostela, Galicia
Novartis Investigative Site, Madrid, Not set
Novartis Investigative Site, Madrid, Not set
Novartis Investigative Site, Madrid, Not set
Novartis Investigative Site, Malmo, Not set
Novartis Investigative Site, Umea, Not set
Novartis Investigative Site, Bellinzona, Not set
Novartis Investigative Site, Geneve 14, Not set
Novartis Investigative Site, St Gallen, Not set
Novartis Investigative Site, Taipei, Not set
Novartis Investigative Site, Taipei, Not set
Novartis Investigative Site, Taoyuan, Not set
Novartis Investigative Site, Adana, Not set
Novartis Investigative Site, Ankara, Not set
Novartis Investigative Site, Istanbul, Not set
Novartis Investigative Site, Izmir, Not set
Novartis Investigative Site, Sutton, Surrey
Novartis Investigative Site, Cambridge, Not set
Novartis Investigative Site, Liverpool, Not set
Novartis Investigative Site, London, Not set
Novartis Investigative Site, Oxford, Not set
Conditions: Metastatic Pancreatic Ductal Adenocarcinoma
A Study of Pembrolizumab (MK-3475) With or Without Maintenance Olaparib in First-line Metastatic Squamous Non-small Cell Lung Cancer (NSCLC, MK-7339-008/KEYLYNK-008)
Active Not Recruiting
The current study will compare pembrolizumab (MK-3475) plus maintenance olaparib, vs. pembrolizumab plus maintenance olaparib placebo for the treatment of squamous NSCLC. The study's 2 primary hypotheses are:
1. Pembrolizumab plus maintenance olaparib is superior to pembrolizumab plus maintenance olaparib placebo with respect to progression-free survival (PFS) per RECIST 1.1 by blinded independent clinical review (BICR).
2. Pembrolizumab plus maintenance olaparib is superior to pembrolizumab pl... Read More
The current study will compare pembrolizumab (MK-3475) plus maintenance olaparib, vs. pembrolizumab plus maintenance olaparib placebo for the treatment of squamous NSCLC. The study's 2 primary hypotheses are:
1. Pembrolizumab plus maintenance olaparib is superior to pembrolizumab plus maintenance olaparib placebo with respect to progression-free survival (PFS) per RECIST 1.1 by blinded independent clinical review (BICR).
2. Pembrolizumab plus maintenance olaparib is superior to pembrolizumab plus maintenance olaparib placebo with respect to overall survival (OS).
As of Amendment 07, there will be no further analyses for OS and patient-reported outcome assessments. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/06/2025
Locations: Alabama Oncology Bruno Cancer Center ( Site 0001), Birmingham, Alabama +177 locations
Alabama Oncology Bruno Cancer Center ( Site 0001), Birmingham, Alabama
Disney Family Cancer Center ( Site 0005), Burbank, California
Boca Raton Regional Hospital ( Site 0018), Boca Raton, Florida
Mid-Florida Cancer Centers ( Site 0022), Orange City, Florida
H. Lee Moffitt Cancer Center and Research Institute ( Site 0024), Tampa, Florida
Columbus Regional Research Institute ( Site 0099), Columbus, Georgia
Mount Sinai Hospital Medical Center ( Site 0035), Chicago, Illinois
Oncology of Northshore ( Site 0036), Rolling Meadows, Illinois
Methodists Hospitals/Premier Oncology Hematology Associates ( Site 0039), Merrillville, Indiana
MedStar Franklin Square Medical Center ( Site 0044), Baltimore, Maryland
Barbara Ann Karmanos Cancer Institute ( Site 0046), Detroit, Michigan
Hattiesburg Clinic ( Site 0051), Hattiesburg, Mississippi
Frontier Oncology ( Site 0052), Billings, Montana
Bozeman Health Deaconness Cancer Center ( Site 0053), Bozeman, Montana
Waverly Hematology Oncology ( Site 0054), Cary, North Carolina
Thompson Cancer Survival Center ( Site 2812), Knoxville, Tennessee
Renovatio Clinical ( Site 0074), The Woodlands, Texas
Cancer Care Northwest ( Site 0083), Spokane Valley, Washington
Hospital Italiano Regional del Sur ( Site 0509), Bahia Blanca, Buenos Aires
Instituto de Investigaciones Clinicas Mar del Plata ( Site 0516), Mar del Plata, Buenos Aires
Hospital Britanico de Buenos Aires ( Site 0500), Buenos Aires, Caba
Instituto Medico Rio Cuarto ( Site 0501), Rio Cuarto, Cordoba
Sanatorio Parque ( Site 0515), Rosario, Santa Fe
Centro Oncológico de Rosario ( Site 0507), Rosario, Santa Fe
Centro Medico San Roque ( Site 0506), San Miguel de Tucuman, Tucuman
Hospital Italiano de Buenos Aires ( Site 0511), Buenos Aires, Not set
Clínica Universitaria Reina Fabiola ( Site 0505), Cordoba, Not set
Sanatorio Privado San Geronimo S.R.L ( Site 0510), Santa Fe, Not set
Liverpool Hospital ( Site 1201), Liverpool, New South Wales
Southern Medical Day Care Centre ( Site 1200), Wollongong, New South Wales
Townsville General Hospital ( Site 1202), Townsville, Queensland
Monash Cancer Centre ( Site 1205), Clayton, Victoria
Ordensklinikum Linz GmbH Elisabethinen ( Site 1307), Linz, Oberosterreich
Klinikum Wels-Grieskirchen ( Site 1304), Wels, Oberosterreich
Innsbruck LKH ( Site 1302), Innsbruck, Tirol
Social Medical Center - Otto Wagner Hospital ( Site 1301), Vienna, Wien
Krankenhaus Nord - Klinik Floridsdorf ( Site 1300), Wien, Not set
Hospital Sao Rafael ( Site 0258), Salvador - BA, Bahia
Instituto do Cancer do Ceara ( Site 0251), Fortaleza, Ceara
Oncologica do Brasil ( Site 0256), Belem, Para
Hospital Tacchini ( Site 0265), Bento Goncalves, Rio Grande Do Sul
Irmandade da Santa Casa de Misericordia de Porto Alegre ( Site 0255), Porto Alegre, Rio Grande Do Sul
Centro de Novos Tratamentos Itajai - Clinica de Neoplasias Litoral ( Site 0252), Itajai, Santa Catarina
Hospital de Base de Sao Jose de Rio Preto ( Site 0254), Sao Jose Rio Preto, Sao Paulo
Instituto Nacional do Cancer Jose Alencar Gomes da Silva INCA ( Site 0253), Rio de Janeiro, Not set
Instituto do Cancer do Estado de Sao Paulo - ICESP ( Site 0250), Sao Paulo, Not set
Hospital Paulistano - Amil Clinical Research ( Site 0263), Sao Paulo, Not set
Real e Benemerita Associacao Portuguesa de Beneficencia ( Site 0260), Sao Paulo, Not set
Nova Scotia Health Authority ( Site 0103), Halifax, Nova Scotia
Hamilton Health Sciences-Juravinski Cancer Centre ( Site 0107), Hamilton, Ontario
Kingston Health Sciences Centre ( Site 0102), Kingston, Ontario
Stronach Regional Cancer Centre ( Site 0100), Newmarket, Ontario
CISSS de la Monteregie-Centre ( Site 0101), Greenfield Park, Quebec
Hopital Cite de la Sante de Laval ( Site 0105), Laval, Quebec
CIUSSS Ouest de l Ile - St-Mary s Hospital ( Site 0110), Montreal, Quebec
CIUSSS de la Mauricie et du Centre du Quebec ( Site 0106), Trois-Rivieres, Quebec
Centre Hospitalier De Chauny ( Site 1411), Chauny, Aisne
CHU Caen ( Site 1406), Caen, Calvados
CHU Angers ( Site 1405), Angers, Maine-et-Loire
Institut De Cancerologie De Lorraine ( Site 1409), Vandoeuvre les Nancy, Meurthe-et-Moselle
Hopital Robert Schuman ( Site 1402), Vantoux, Moselle
Centre Jean Perrin ( Site 1407), Clermont Ferrand, Puy-de-Dome
Centre Hospitalier de Pau ( Site 1412), Pau, Pyrenees-Atlantiques
CHU de Rouen ( Site 1403), Rouen, Seine-Maritime
Hopital d'Instruction des Armees Begin ( Site 1413), Saint-Mande, Val-de-Marne
Studienzentrum Aschaffenburg ( Site 1575), Aschaffenburg, Bayern
Klinikum Bogenhausen Staedt. Klinikum Muenchen GmbH ( Site 1573), Muenchen, Bayern
Klinikum der LMU ( Site 1550), Munich, Bayern
Universitaetsklinikum Regensburg ( Site 1562), Regensburg, Bayern
Klinikum Wuerzburg Mitte gGmbH ( Site 1559), Wuerzburg, Bayern
Universitaetsklinikum Frankfurt ( Site 1563), Frankfurt, Hessen
Pneumologische Lehrklinik Universitaet Goettingen ( Site 1551), Immenhausen, Hessen
Universitaetsmedizin Goettingen ( Site 1557), Goettingen, Niedersachsen
Universitaetsklinikum Bonn ( Site 1574), Bonn, Nordrhein-Westfalen
Kliniken Essen Mitte ( Site 1567), Essen, Nordrhein-Westfalen
InVo-Institut fuer Versorgungsforschung in der Onkologie ( Site 1564), Koblenz, Rheinland-Pfalz
Helios Klinikum Erfurt GmbH ( Site 1552), Erfurt, Thuringen
Katholisches Marienkrankenhaus gGmbH ( Site 1572), Hamburg, Not set
National Hospital Organization Nagoya Medical Center ( Site 0806), Nagoya, Aichi
Aichi Cancer Center Hospital ( Site 0803), Nagoya, Aichi
National Cancer Center Hospital East ( Site 0801), Kashiwa, Chiba
Kurume University Hospital ( Site 0814), Kurume, Fukuoka
Kanazawa University Hospital ( Site 0811), Kanazawa, Ishikawa
Kanagawa Cancer Center ( Site 0807), Yokohama, Kanagawa
Sendai Kousei Hospital ( Site 0812), Sendai, Miyagi
Kansai Medical University Hospital ( Site 0804), Hirakata, Osaka
National Hospital Organization Kinki-chuo Chest Medical Center ( Site 0813), Sakai, Osaka
Shizuoka Cancer Center Hospital and Research Institute ( Site 0802), Sunto-gun, Shizuoka
National Hospital Organization Kyushu Medical Center ( Site 0805), Fukuoka, Not set
Niigata Cancer Center Hospital ( Site 0808), Niigata, Not set
Okayama University Hospital ( Site 0810), Okayama, Not set
Osaka International Cancer Institute ( Site 0809), Osaka, Not set
The Cancer Institute Hospital of JFCR ( Site 0800), Tokyo, Not set
Chungbuk National University Hospital ( Site 1002), Cheongju si, Chungbuk
National Cancer Center ( Site 1006), Goyang-si, Kyonggi-do
The Catholic University of Korea St. Vincent s Hospital ( Site 1003), Gyeonggi-do, Kyonggi-do
Ajou University Hospital ( Site 1004), Suwon, Kyonggi-do
Gyeongsang National University Hospital ( Site 1005), Jinju, Kyongsangnam-do
Asan Medical Center ( Site 1007), Songpa-gu, Seoul
Seoul National University Hospital ( Site 1000), Seoul, Not set
Severance Hospital Yonsei University Health System ( Site 1001), Seoul, Not set
Korea University Guro Hospital ( Site 1008), Seoul, Not set
Investigacion Onco Farmaceutica S de RL de CV ( Site 0300), La Paz, Baja California Sur
Hospital Civil de Guadalajara Fray Antonio Alcalde ( Site 0334), Guadalajara, Jalisco
Axis Heilsa S. de R.L. de C.V. ( Site 0301), Monterrey, Nuevo Leon
CLIMERS Clinical Medical Research ( Site 0306), Orizaba, Veracruz
Arke Estudios Clinicos ( Site 0333), Cdmx, Not set
FAICIC Clinical Research ( Site 0303), Veracruz, Not set
MidCentral DHB Palmerston North Hospital ( Site 1102), Palmerston North, Manawatu-Wanganui
Capital & Coast District Health Board - Wellington Hospital ( Site 1101), Wellington, Not set
Samodzielny Publiczny Zespol Gruzlicy i Chorob Pluc ( Site 2417), Olsztyn, Dolnoslaskie
Wielospecjalistyczny Szpital SPZOZ w Zgorzelcu ( Site 2404), Zgorzelec, Dolnoslaskie
Krakowski Szpital Specjalistyczny im Jana Pawla II ( Site 2420), Krakow, Malopolskie
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie (, Warszawa, Mazowieckie
Szpital Rejonowy im. dr Jozefa Rostka ( Site 2402), Raciborz, Slaskie
Przychodnia Lekarska Komed ( Site 2416), Konin, Wielkopolskie
MED-POLONIA Sp. z o.o. ( Site 2419), Poznan, Wielkopolskie
Cardiomed SRL Cluj-Napoca ( Site 2504), Cluj Napoca, Cluj
S.C. Radiotherapy Center Cluj S.R.L ( Site 2507), Cluj-Napoca, Cluj
S.C. Centrul de Oncologie Sf. Nectarie SRL ( Site 2508), Craiova, Dolj
Policlinica Oncomed SRL ( Site 2505), Timisoara, Timis
S.C.Focus Lab Plus S.R.L ( Site 2502), Bucuresti, Not set
Spitalul Clinic Judetean de Urgenta Sf Apostol Andrei ( Site 2501), Constanta, Not set
Moscow Regional Oncological Dispensary ( Site 2028), Balashikha, Moskovskaya Oblast
Russian Oncological Research Center n.a. N.N.Blokhin of MoH ( Site 2000), Moscow, Moskva
First Moscow State Medical University n.a. I.M.Sechenov ( Site 2024), Moscow, Moskva
Moscow Research Oncology Institute named after P.A. Hertsen ( Site 2009), Moscow, Moskva
FSAI Treatment and Rehabilitation Centre of the MoH and SD of RF ( Site 2006), Moscow, Moskva
Nizhniy Novgorod Region Oncology Dispensary ( Site 2026), Nizhniy Novgorod, Nizhegorodskaya Oblast
Budgetary Healthcare Institution of Omsk Region Clinical Oncology Dispensary-Chemotherapy #1 ( Site, Omsk, Omskaya Oblast
SBHI Samara Regional Clinical Oncology Dispensary ( Site 2016), Samara, Samarskaya Oblast
SBHI Leningrad Regional Clinical Hospital ( Site 2002), Saint Petersburg, Sankt-Peterburg
SPb Central Clinical Railway Hospital ( Site 2003), Saint Petersburg, Sankt-Peterburg
National Medical Research Center of Oncology N.A. N.N. Petrov ( Site 2004), Saint Petersburg, Sankt-Peterburg
SPb SBHI City Clinical Oncological Dispensary ( Site 2001), Saint Petersburg, Sankt-Peterburg
Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 2021), Kazan, Tatarstan, Respublika
Hospital Duran i Reynals ( Site 1710), Hospitalet de Llobregat, Barcelona
Complejo Hospitalario de Jaen ( Site 1713), Jaen, La Coruna
Hospital Sant Creu i Sant Pau ( Site 1711), Barcelona, Not set
Hospital Universitario 12 de Octubre ( Site 1716), Madrid, Not set
Complejo Hospitalario de Malaga ( Site 1714), Malaga, Not set
Hospital Universitario Virgen Macarena ( Site 1712), Sevilla, Not set
Chang Gung Medical Foundation. Kaohsiung Branch ( Site 0907), Kaohsiung, Not set
China Medical University Hospital ( Site 0904), Taichung, Not set
National Cheng Kung University Hospital ( Site 0905), Tainan, Not set
National Taiwan University Hospital ( Site 0900), Taipei, Not set
Mackay Memorial Hospital ( Site 0902), Taipei, Not set
Chang Gung Medical Foundation.Linkou Branch ( Site 0903), Taoyuan, Not set
Namik Kemal Universitesi Tip Fakultesi ( Site 2100), Tekirdag, Tekirdas
Baskent Unv. Adana Uyg. ve Arast. Hastanesi ( Site 2101), Adana, Not set
Gazi Universitesi Tip Fakultesi ( Site 2104), Ankara, Not set
Ankara Sehir Hastanesi ( Site 2105), Ankara, Not set
Bezmialem Vakif Univ. Tıp Fakultesi Hastanesi Tibbi Onkoloji Bolumu ( Site 2107), Istanbul, Not set
Göztepe Prof. Dr. Süleyman Yalçın Şehir Hastanesi-oncology ( Site 2103), Istanbul, Not set
Ege Universitesi Tip Fakultesi ( Site 2109), Izmir, Not set
Erciyes Universitesi Tip Fakultesi ( Site 2108), Kayseri, Not set
Ondokuz Mays Üniversitesi Tp Fakültesi Hastanesi-Oncology ( Site 2106), Samsun, Not set
Cherkasy Regional Oncology Dispensary ( Site 2225), Cherkasy, Cherkaska Oblast
City Clinical Hosp.4 of DCC ( Site 2215), Dnipro, Dnipropetrovska Oblast
MI Precarpathian Clinical Oncology Center ( Site 2218), Ivano-Frankivsk, Ivano-Frankivska Oblast
Grigoriev Institute for medical Radiology NAMS of Ukraine ( Site 2226), Kharkiv, Kharkivska Oblast
Regional Centre of Oncology-Thoracic organs ( Site 2219), Kharkiv, Kharkivska Oblast
PP PPC Acinus Medical and Diagnostic Centre ( Site 2223), Kropyvnytskyi, Kirovohradska Oblast
Medical Center Asklepion LLC ( Site 2243), Khodosivka, Kyivska Oblast
Kyiv City Clinical Oncology Centre ( Site 2224), Kyiv, Kyivska Oblast
Medical and Diagnostic Centre LLC Dobryi Prognoz ( Site 2227), Kyiv, Kyivska Oblast
MI Odessa Regional Oncological Centre ( Site 2222), Odesa, Odeska Oblast
Central City Clinical Hospital ( Site 2221), Uzhgorod, Zakarpatska Oblast
Medical Center Verum ( Site 2228), Kyiv, Not set
Southend University Hospital NHS Foundation Trust ( Site 1913), Westcliff-on-Sea, Essex
Barts Health NHS Trust - St Bartholomew s Hospital ( Site 1923), London, London, City Of
Chelsea and Westminster Hospital ( Site 1901), London, London, City Of
Newcastle Freeman Hospital ( Site 1902), Newcastle-upon-Tyne, Newcastle Upon Tyne
West Suffolk Hospitals NHS Trust ( Site 1919), Bury Saint Edmunds, Suffolk
Singleton Hospital ( Site 1909), Swansea, Wales
Colchester General Hospital ( Site 1911), Colchester, Worcestershire
Birmingham Heartlands Hospital ( Site 1910), Birmingham, Not set
Western General Hospital, Edinburgh ( Site 1924), Edinburg, Not set
Conditions: Carcinoma, Squamous Cell, Non-small-cell Lung
A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression
Completed
This Phase 3 study is designed to compare the efficacy and safety of mirvetuximab soravtansine (MIRV) vs. IC chemotherapy in participants with platinum-resistant high-grade epithelial ovarian cancer, primary peritoneal, or fallopian tube cancer, whose tumors express a high-level of FRα. Participants will be, in the opinion of the Investigator, appropriate for single-agent therapy for their next line of therapy. The FRα positivity will be defined by the Ventana FOLR1 (FOLR1-2.1) CDx assay.
This Phase 3 study is designed to compare the efficacy and safety of mirvetuximab soravtansine (MIRV) vs. IC chemotherapy in participants with platinum-resistant high-grade epithelial ovarian cancer, primary peritoneal, or fallopian tube cancer, whose tumors express a high-level of FRα. Participants will be, in the opinion of the Investigator, appropriate for single-agent therapy for their next line of therapy. The FRα positivity will be defined by the Ventana FOLR1 (FOLR1-2.1) CDx assay. Read Less
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
01/05/2025
Locations: University of Alabama at Birmingham (UAB) GYN Oncology, Birmingham, Alabama +213 locations
University of Alabama at Birmingham (UAB) GYN Oncology, Birmingham, Alabama
Alaska Women's Cancer Care, Anchorage, Alaska
Arizona Oncology Associates, PC - HAL - USOR, Phoenix, Arizona
Mayo Clinic, Phoenix, Arizona
USOR: Arizona Oncology Associates, PC - HOPE, Tucson, Arizona
University of Arizona Cancer Center, Tucson, Arizona
UCLA - JCCC Dept of OBGYN - Women's Health Clinical Research Unit, Los Angeles, California
Hoag Cancer Center, Newport Beach, California
University of California San Francisco, San Francisco, California
Olive View - UCLA Medical Center, Sylmar, California
Kaiser Permanente Oncology Clinical Trials, Vallejo, California
USOR: Rocky Mountain Cancer Centers, Lakewood, Colorado
Yale University School of Medicine, New Haven, Connecticut
Florida Cancer Specialist South Division, Fort Myers, Florida
Mayo Clinic Jacksonville, Jacksonville, Florida
Women's Care Florida / Women's Cancer Associates, Saint Petersburg, Florida
Florida Cancer Specialist North Division, Saint Petersburg, Florida
Sarasota Memorial Hospital, Sarasota, Florida
Florida Cancer Specialists, Tallahassee, Florida
Florida Cancer Specialist East Division, West Palm Beach, Florida
Memorial University Medical Center, Savannah, Georgia
Hawaii Pacific Health - Kapiolani Medical Center for Women and Children, Honolulu, Hawaii
Illinois Cancer Specialists, Arlington Heights, Illinois
University of Chicago, Chicago, Illinois
Dr. Sudarshan K. Sharma, Ltd., Hinsdale, Illinois
Community Health Network, Indianapolis, Indiana
University of Kansas Cancer Center, Westwood, Kansas
St. Elizabeth Healthcare, Edgewood, Kentucky
Norton Cancer Institute, Louisville, Kentucky
Ochnser Medical Center Jefferson, New Orleans, Louisiana
WK Physicians Network/Gynecologic Oncology Associates, Shreveport, Louisiana
Holy Cross Hospital, Silver Spring, Maryland
USOR: Maryland Oncology Hematology, P.A., Silver Spring, Maryland
Tufts Medical Center, Boston, Massachusetts
Baystate Medical Center, Springfield, Massachusetts
University of Massachusetts, Worcester, Massachusetts
St. Joseph Mercy Hospital, Ann Arbor, Michigan
Karmanos Cancer Institute, Detroit, Michigan
Mayo Clinic Rochester, Rochester, Minnesota
USOR: Minnesota Oncology Hematology, PA, Woodbury, Minnesota
HCA Midwest Kansas City/ Sarah Cannon, Kansas City, Missouri
Sletten Cancer Institute, Great Falls, Montana
Center of Hope, Reno, Nevada
The Valley Hospital, Inc, Ridgewood, New Jersey
Holy Name Medical Center, Teaneck, New Jersey
Columbia University Medical Center, New York, New York
FirstHealth of the Carolinas Outpatient Cancer Center, Pinehurst, North Carolina
USOR: OHC - Oncology_Hematology Care Clinical Trials, Inc., Cincinnati, Ohio
MetroHealth Medical Center, Cleveland, Ohio
Cleveland Clinic, Cleveland, Ohio
Columbus NCORP, Columbus, Ohio
Zangmeister Cancer Center, Columbus, Ohio
Oncology_Hematology Care Clinical Trials, LLC, Fairfield, Ohio
The Ohio State University Wexner Medical Center, Hilliard, Ohio
Stephenson Cancer Center, Oklahoma City, Oklahoma
Oklahoma Cancer Specialists and Research Institute, Tulsa, Oklahoma
USOR: Willamette Valley Cancer Institute and Research Center, Eugene, Oregon
Legacy Gynecologic Oncology, Portland, Oregon
USOR: Northwest Cancer Specialists, P.C., Portland, Oregon
University of Pennsylvania, Philadelphia, Pennsylvania
Fox Chase Cancer Center, Philadelphia, Pennsylvania
Magee-Women's Hospital-UPMC, Pittsburgh, Pennsylvania
West Penn Hospital, Pittsburgh, Pennsylvania
Women & Infants Hospital of Rhode Island, Providence, Rhode Island
Tennessee Oncology / Sarah Cannon Research Institute, Nashville, Tennessee
USOR: Texas Oncology-South Austin, Austin, Texas
USOR: Texas Oncology - Fort Worth Cancer Center, Fort Worth, Texas
University of Texas, Memorial Hermann, Houston, Texas
USOR: Texas Oncology - McAllen South Second, McAllen, Texas
USOR: Texas Oncology - San Antonio, San Antonio, Texas
USOR: Texas Oncology, P.A., Sugar Land, Texas
USOR: Texas Oncology - The Woodlands, Gynecologic Oncology, The Woodlands, Texas
USOR: Texas Oncology - Tyler, Tyler, Texas
USOR: Texas Oncology, P.A., Webster, Texas
University of Virginia Health System, Charlottesville, Virginia
USOR: Virginia Cancer Specialists, PC, Gainesville, Virginia
Kadlec Clinic Hematology & Oncology, Kennewick, Washington
West Virginia University- MBRCC, Morgantown, West Virginia
Newcastle Private Hospital, New Lambton Heights, New South Wales
Prince of Wales Hospital, Randwick, New South Wales
Monash Health, Clayton, Victoria
Oncology Clinics Victoria (OCV) - Cabrini Malvern Hospital Location, Malvern, Victoria
Royal North Shore Hospital, Saint Leonards, Not set
Burnside War Memorial Hospital - The Brian Fricker Oncology Centre, Toorak Gardens, Not set
OLV Ziekenhuis, Aalst, Not set
AZ Klina, Brasschaat, Not set
Universitair Ziekenhuis Antwerpen (UZA) - Borstkliniek, Edegem, Not set
AZ St-Lucas, Gent, Not set
UZ Leuven, Leuven, Not set
Complex Oncology Center, Burgas, Not set
UMHAT Georgi Stranski, Pleven, Not set
Acibadem City Clinic Tokuda Hospital, Sofia, Not set
UMHAT "Sv. Ivan Rilski", EAD, Sofia, Sofia, Not set
Tom Baker Cancer Centre, Calgary, Alberta
Cross Cancer Institute, Edmonton, Alberta
The Ottawa Hospital General Campus, Ottawa, Ontario
Sunnybrook Health Sciences Center, Toronto, Ontario
Princess Margaret Cancer Centre - University Health Network, Toronto, Ontario
McGill University Health Centre, Montreal, Quebec
Centre Hospitalier de L'Universite de Montreal, Montréal, Quebec
Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec
Anhui Provincial Cancer Hospital, Hefei, Anhui
Fujian Cancer Hospital, Fuzhou, Fujian
Zhongshan Hospital Xiamen University, Xiamen, Fujian
Sun Yat-sen University, Cancer Center, Guangzhou, Guangdong
Wuhan Union Hospital of China, Wuhan, Hubei
Zhongnan Hospital of Wuhan University, Wuhan, Hubei
Hubei Cancer Hospital, Wuhan, Hubei
The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu
The First Hospital of Jilin University, Changchun, Jilin
Liaoning Cancer Hospital, Shenyang, Liaoning
The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shanxi
Peking University First Hospital, Beijing, Not set
Beijing Cancer Hospital, Beijing, Not set
Fudan University Shanghai Cancer Center, Shanghai, Not set
Tianjin Medical University Cancer Institute & Hospital, Tianjin, Not set
Fakultní nemocnice Ostrava, Ostrava, Not set
Všeobecná fakultní nemocnice v Praze, Praha 2, Not set
KNTB a.s. Zlín, Zlín, Not set
Institut Claudius Regaud, Toulouse, Cedex 9
Centre Oscar Lambret, Lille, Cedex B.P 307
Institut de cancérologie de l'ouest, site Angers, Angers, Cedex
CHRU Besançon, Besançon Cedex, Not set
Institut Bergonie, Bordeaux Cedex, Not set
Centre Leon Berard, Lyon Cedex, Not set
Institut Paoli Calmettes, Marseille, Not set
Cochin Hospital, Paris, Not set
Groupe Hospitalier Diaconesses Croix Saint-Simon, Paris, Not set
Centre Hospitalier Lyon Sud, Pierre-Bénite, Not set
Centre Armoricain de radiothérapie, imagerie médicale et oncologie, CARIO, Plerin, Not set
Institut Curie, Saint Cloud, Not set
ICO Centre René Gauducheau, St. Herblain CEDEX, Not set
Institut de cancérologie de Lorraine, Vandoeuvre les Nancy_ Cedex, Not set
Gustave Roussy, Villejuif Cedex, Not set
Ulm University Hospital Klinik für Frauenheilkunde und Geburtshilfe, Ulm, Baden-Württemberg
UMG Göttingen Frauenklinik, Göttingen, Niedersachsen
Universitätsklinikum Carl Gustav Carus Dresden, Dresden, Saxony
Universitätsklinikum Bonn, Bonn, Not set
Städtisches Klinikum Dessau, Zentrum für Klinische Studien, Dessau, Not set
Klinikum Dortmund gGmbH / Frauenklinik, Dortmund, Not set
University Hospital Freiburg, Freiburg, Not set
UKGM Standort Giessen, Giessen, Not set
Mammazentrum Hamburg am Krankenhaus Jerusalem, Hamburg, Not set
Wolfson Medical Center, Holon, Not set
Hadassah Ein Kerem Medical center, Jerusalem, Not set
Meir Medical Center, Kfar Saba, Not set
Sheba Medical Center, Ramat Gan, Not set
Kaplan Medical Center, Rehovot, Not set
Ziv Medical Center, Safed, Not set
IOV Istituto Oncologico, Padova, PD
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, Brescia, Not set
ASST Lecco- Ospedale A.Manzoni, Lecco, Not set
IRCCS - Istituto Europeo di Oncologia (The European Institute of Oncology) (IEO), Milan, Not set
INT Pascale, Naples, Not set
Centro Operativo Studi Clinici S.C.Oncologia Medica, Perugia, Not set
Oncologia Azienda Osc-IRCCS Reggio Emilia, Reggio Emilia, Not set
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Not set
Azienda Ospedaliera Città Della Salute E Della Scienza Di Torino, Torino, Not set
Ospedale Mauriziano Umberto I, Torino, Not set
Istituto Oncologico Candiolo, Torino, Not set
National Cancer Center - Center for Uterine Cancer, Gyeonggi-do, Not set
Seoul National University Bundang Hospital, Seongnam-si, Not set
Seoul National University Hospital, Seoul, Not set
Severance Hospital, Seoul, Not set
University of Ulsan College of Medicine - Asan Medical Center, Seoul, Not set
Samsung Medical Center, Seoul, Not set
Amsterdam UMC, Amsterdam, Not set
Maastricht UMC, Maastricht, Not set
Radboud University Medical Center, Nijmegen, Not set
Erasmus Medical Center, Rotterdam, Not set
Medical University of Gdansk, Gdańsk, Not set
Samodzielny publiczny szpital kliniczny nr 1, Lublin, Not set
Wojewódzki Szpital Specjalistyczny, Oddzial Kliniczny Ginekologii Onkologiczne, Olsztyn, Not set
Wielkopolskie Centrum Onkologii, Poznań, Not set
Szpital Kliniczny im. Ks. Anny Mazowieckiej, Warszawa, Not set
Fundação Champalimaud, Lisbon, Not set
Hospital da Luz, S.A, Lisbon, Not set
Centro Hospitalar de Lisboa Norte, E.P.E. - Hospital de Santa Maria, Lisbon, Not set
Hospital Beatriz Angelo, Loures, Not set
BIH of Omsk Region "Clinical Oncology Dispensary", Omsk, Omsk Oblast
LLC "VitaMed", Moscow, Not set
Leningrad regional oncology dispensa, St-Petersburg, Not set
State Autonomous Healthcare Institution Republican Clinical Oncological Dispensary of the MoH of Republic Bashkortostan, Ufa, Not set
Oncology and Radiology Institute Serbia, Belgrade, Not set
Clinical Center Kragujevac, Kragujevac, Not set
Oncology Institute Vojvodina, Surgical Oncology Clinic, Sremska Kamenica, Not set
Hospital Clínico de Santiago, Santiago de Compostela, A Coruña
H. U. de Jaén, Jaén, Andalucia
Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Madrid
Institut Català d'Oncologia, Badalona, Not set
H. San Pedro de Alcántara, Caceres, Not set
Hospital Provincial de Castellon, Castelló, Not set
Hospital de San Chinarro-Clara Campal, Madrid, Not set
Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Not set
Parc Taulí, Sabadell, Not set
Virgen del Rocío, Sevilla, Not set
Hospital de la Fe, Valencia, Not set
HCU Lozano Blesa, Zaragoza, Not set
Far Eastern Memorial Hospital, New Taipei City, Not set
Mackay Memorial Hospital - Taipei Branch, Taipei City, Not set
Taipei Veterans General Hospital, Taipei City, Not set
Chernihiv Medical Center of Modern Oncology of Chernihiv Regional Council, Chernihiv, Chernihiv Region
Grigoriev Institute for Medical Radiology NAMS of Ukraine, Kharkiv, Kharkiv Region
Communal non-profit enterprise "Khmelnytskyi Regional Antitumor Center" of Khmelnytskoyi Regional Council, Khmelnytskyi, Khmelnytskyi Region
Communal non-profit enterprise "Cherkasy Regional Oncology Dispensary of Cherkasy oblast council", Cherkasy, Not set
Prykarpatskyi Clinical Oncology Center of Ivano-Frankivsk Regional Council, Ivano-Frankivsk, Not set
Peterborough City Hospital, Peterborough, Cambridgeshire
Royal Devon and Exeter Hospital (Wonford), Exeter, Devon
University Hospitals Coventry and Warwickshire, Coventry, Not set
Beatson West of Scotland Cancer Centre, Glasgow, Not set
St Bartholomew's Hospital-Barts Health NHS Trust, London, Not set
University College London Hospital, London, Not set
The Royal Marsden NHS Foundation Trust, London, Not set
The Christie NHS Foundation Trust, Manchester, Not set
Conditions: Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer
97 - 108 of 342